| hsa05200 |
Pathways in cancer |
9,79252E-08 |
1,15449E-05 |
| hsa04520 |
Adherens junction |
7,39557E-07 |
4,35949E-05 |
| hsa05214 |
Glioma |
1,6163E-06 |
6,35179E-05 |
| hsa04510 |
Focal adhesion |
2,99015E-06 |
8,81308E-05 |
| hsa05219 |
Bladder cancer |
1,8227E-05 |
0,000389684 |
| hsa04115 |
p53 signaling pathway |
2,04485E-05 |
0,000389684 |
| hsa05212 |
Pancreatic cancer |
2,32805E-05 |
0,000389684 |
| hsa05218 |
Melanoma |
2,64429E-05 |
0,000389684 |
| hsa05220 |
Chronic myeloid leukemia |
3,38851E-05 |
0,000431434 |
| hsa05215 |
Prostate cancer |
3,65948E-05 |
0,000431434 |
| hsa05131 |
Shigellosis |
5,29757E-05 |
0,000520463 |
| hsa05210 |
Colorectal cancer |
5,29757E-05 |
0,000520463 |
| hsa05213 |
Endometrial cancer |
9,1296E-05 |
0,000827948 |
| hsa04110 |
Cell cycle |
0,000246889 |
0,002079062 |
| hsa04330 |
Notch signaling pathway |
0,000312602 |
0,00245694 |
| hsa04530 |
Tight junction |
0,00035307 |
0,002601566 |
| hsa05211 |
Renal cell carcinoma |
0,000742822 |
0,005151459 |
| hsa05216 |
Thyroid cancer |
0,001176281 |
0,007704297 |
| hsa04350 |
TGF-beta signaling pathway |
0,002643902 |
0,015585109 |
| hsa05222 |
Small cell lung cancer |
0,002643902 |
0,015585109 |
| hsa04722 |
Neurotrophin signaling pathway |
0,003063835 |
0,017200478 |
| hsa04150 |
mTOR signaling pathway |
0,003270942 |
0,017528495 |
| hsa05100 |
Bacterial invasion of epithelial cells |
0,003742191 |
0,01918194 |
| hsa05223 |
Non-small cell lung cancer |
0,003961006 |
0,019457575 |
| hsa04320 |
Dorso-ventral axis formation |
0,004938422 |
0,02328856 |
| hsa04670 |
Leukocyte transendothelial migration |
0,005708391 |
0,025884204 |
| hsa04310 |
Wnt signaling pathway |
0,010271941 |
0,04434721 |
| hsa04930 |
Type II diabetes mellitus |
0,01101112 |
0,04434721 |
| hsa04360 |
Axon guidance |
0,011141968 |
0,04434721 |
| hsa04012 |
ErbB signaling pathway |
0,011284781 |
0,04434721 |
| hsa04144 |
Endocytosis |
0,012202141 |
0,046405425 |
| hsa04720 |
Long-term potentiation |
0,013885275 |
0,051156278 |
| hsa04910 |
Insulin signaling pathway |
0,016017596 |
0,057223949 |
| hsa04010 |
MAPK signaling pathway |
0,019256075 |
0,066770292 |
| GO biological process |
Description |
p-value |
q-value |
| GO:0098727 |
maintenance of cell number |
1,18074E-11 |
2,86585E-08 |
| GO:0031099 |
regeneration |
1,80661E-11 |
2,86585E-08 |
| GO:0042063 |
gliogenesis |
5,6255E-11 |
5,35656E-08 |
| GO:0019827 |
stem cell population maintenance |
7,16618E-11 |
5,35656E-08 |
| GO:0048545 |
response to steroid hormone |
8,44182E-11 |
5,35656E-08 |
| GO:0048732 |
gland development |
1,60944E-09 |
7,27887E-07 |
| GO:0006352 |
DNA-templated transcription, initiation |
1,80215E-09 |
7,27887E-07 |
| GO:0006367 |
transcription initiation from RNA polymerase II promoter |
1,83541E-09 |
7,27887E-07 |
| GO:0060485 |
mesenchyme development |
3,08643E-09 |
1,08801E-06 |
| GO:0010001 |
glial cell differentiation |
4,37721E-09 |
1,38873E-06 |
| GO:0021537 |
telencephalon development |
1,07599E-08 |
3,10338E-06 |
| GO:0021543 |
pallium development |
1,55432E-08 |
4,10941E-06 |
| GO:0030900 |
forebrain development |
2,22731E-08 |
5,43573E-06 |
| GO:0060070 |
canonical Wnt signaling pathway |
2,73224E-08 |
6,19171E-06 |
| GO:2000045 |
regulation of G1/S transition of mitotic cell cycle |
4,4556E-08 |
9,09381E-06 |
| GO:0035690 |
cellular response to drug |
4,58613E-08 |
9,09381E-06 |
| GO:0010718 |
positive regulation of epithelial to mesenchymal transition |
5,52864E-08 |
1,03179E-05 |
| GO:2000027 |
regulation of animal organ morphogenesis |
5,99345E-08 |
1,05639E-05 |
| GO:0000082 |
G1/S transition of mitotic cell cycle |
7,21576E-08 |
1,16484E-05 |
| GO:0030522 |
intracellular receptor signaling pathway |
7,6866E-08 |
1,16484E-05 |
| GO:0048608 |
reproductive structure development |
7,71021E-08 |
1,16484E-05 |
| GO:0001655 |
urogenital system development |
8,46856E-08 |
1,17792E-05 |
| GO:0110110 |
positive regulation of animal organ morphogenesis |
8,74256E-08 |
1,17792E-05 |
| GO:0061458 |
reproductive system development |
8,91059E-08 |
1,17792E-05 |
| GO:0048762 |
mesenchymal cell differentiation |
1,28767E-07 |
1,63412E-05 |
| GO:1902806 |
regulation of cell cycle G1/S phase transition |
1,8518E-07 |
2,25965E-05 |
| GO:0035019 |
somatic stem cell population maintenance |
2,19396E-07 |
2,57801E-05 |
| GO:0044843 |
cell cycle G1/S phase transition |
2,28165E-07 |
2,58529E-05 |
| GO:0050679 |
positive regulation of epithelial cell proliferation |
2,48543E-07 |
2,71909E-05 |
| GO:0050673 |
epithelial cell proliferation |
3,14393E-07 |
3,32484E-05 |
| GO:0002065 |
columnar/cuboidal epithelial cell differentiation |
4,75953E-07 |
4,74957E-05 |
| GO:0007219 |
Notch signaling pathway |
4,79055E-07 |
4,74957E-05 |
| GO:0042246 |
tissue regeneration |
5,06149E-07 |
4,86614E-05 |
| GO:0001706 |
endoderm formation |
6,683E-07 |
6,23609E-05 |
| GO:0021782 |
glial cell development |
7,1618E-07 |
6,31159E-05 |
| GO:0021987 |
cerebral cortex development |
7,1618E-07 |
6,31159E-05 |
| GO:0061013 |
regulation of mRNA catabolic process |
7,37716E-07 |
6,32568E-05 |
| GO:0034248 |
regulation of cellular amide metabolic process |
7,84088E-07 |
6,54637E-05 |
| GO:0060562 |
epithelial tube morphogenesis |
8,52316E-07 |
6,93355E-05 |
| GO:0007178 |
transmembrane receptor protein serine/threonine kinase signaling pathway |
8,96969E-07 |
7,11438E-05 |
| GO:1903829 |
positive regulation of cellular protein localization |
9,4538E-07 |
7,26509E-05 |
| GO:2000826 |
regulation of heart morphogenesis |
9,88885E-07 |
7,26509E-05 |
| GO:0071383 |
cellular response to steroid hormone stimulus |
9,91883E-07 |
7,26509E-05 |
| GO:0050678 |
regulation of epithelial cell proliferation |
1,00757E-06 |
7,26509E-05 |
| GO:0001837 |
epithelial to mesenchymal transition |
1,08708E-06 |
7,4976E-05 |
| GO:0072073 |
kidney epithelium development |
1,08708E-06 |
7,4976E-05 |
| GO:0001704 |
formation of primary germ layer |
1,16514E-06 |
7,86501E-05 |
| GO:0001822 |
kidney development |
1,21697E-06 |
8,04372E-05 |
| GO:0002064 |
epithelial cell development |
1,27828E-06 |
8,27657E-05 |
| GO:0043254 |
regulation of protein complex assembly |
1,30512E-06 |
8,28131E-05 |
| GO:0030879 |
mammary gland development |
1,40443E-06 |
8,73677E-05 |
| GO:0060231 |
mesenchymal to epithelial transition |
1,50469E-06 |
9,18043E-05 |
| GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle |
1,68932E-06 |
0,000101124 |
| GO:0030111 |
regulation of Wnt signaling pathway |
1,75837E-06 |
0,000103308 |
| GO:0060828 |
regulation of canonical Wnt signaling pathway |
1,88723E-06 |
0,000108863 |
| GO:0007050 |
cell cycle arrest |
1,93182E-06 |
0,000109445 |
| GO:0071496 |
cellular response to external stimulus |
2,00024E-06 |
0,000110649 |
| GO:0035270 |
endocrine system development |
2,02282E-06 |
0,000110649 |
| GO:0010717 |
regulation of epithelial to mesenchymal transition |
2,17553E-06 |
0,000116986 |
| GO:0007162 |
negative regulation of cell adhesion |
2,21503E-06 |
0,000117125 |
| GO:0034330 |
cell junction organization |
2,3353E-06 |
0,00012146 |
| GO:0006913 |
nucleocytoplasmic transport |
2,42344E-06 |
0,000124011 |
| GO:0001503 |
ossification |
2,48597E-06 |
0,000125191 |
| GO:0035850 |
epithelial cell differentiation involved in kidney development |
2,60595E-06 |
0,000129183 |
| GO:0072001 |
renal system development |
2,73256E-06 |
0,000133376 |
| GO:0051169 |
nuclear transport |
2,79278E-06 |
0,000134249 |
| GO:1902807 |
negative regulation of cell cycle G1/S phase transition |
2,86986E-06 |
0,000135633 |
| GO:0003177 |
pulmonary valve development |
2,90707E-06 |
0,000135633 |
| GO:0035987 |
endodermal cell differentiation |
3,11348E-06 |
0,000143158 |
| GO:0007492 |
endoderm development |
3,20663E-06 |
0,000145335 |
| GO:1903311 |
regulation of mRNA metabolic process |
3,49043E-06 |
0,00015597 |
| GO:0010464 |
regulation of mesenchymal cell proliferation |
3,7703E-06 |
0,000166136 |
| GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
3,92871E-06 |
0,000170745 |
| GO:0007409 |
axonogenesis |
4,2521E-06 |
0,000182302 |
| GO:0045637 |
regulation of myeloid cell differentiation |
4,34796E-06 |
0,000183926 |
| GO:0003151 |
outflow tract morphogenesis |
4,58412E-06 |
0,000191365 |
| GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway |
5,06508E-06 |
0,000208697 |
| GO:0050769 |
positive regulation of neurogenesis |
5,3439E-06 |
0,000217362 |
| GO:1903706 |
regulation of hemopoiesis |
5,54899E-06 |
0,000222847 |
| GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity |
5,72977E-06 |
0,000225263 |
| GO:0051222 |
positive regulation of protein transport |
5,75116E-06 |
0,000225263 |
| GO:0043401 |
steroid hormone mediated signaling pathway |
5,89309E-06 |
0,000228007 |
| GO:0030857 |
negative regulation of epithelial cell differentiation |
6,0665E-06 |
0,000231889 |
| GO:0007369 |
gastrulation |
6,29588E-06 |
0,000235546 |
| GO:0006402 |
mRNA catabolic process |
6,31067E-06 |
0,000235546 |
| GO:0006417 |
regulation of translation |
7,31131E-06 |
0,000269722 |
| GO:0031669 |
cellular response to nutrient levels |
7,99075E-06 |
0,000291399 |
| GO:1904951 |
positive regulation of establishment of protein localization |
8,19237E-06 |
0,000295357 |
| GO:0002053 |
positive regulation of mesenchymal cell proliferation |
8,85418E-06 |
0,000314716 |
| GO:0033002 |
muscle cell proliferation |
8,92774E-06 |
0,000314716 |
| GO:0090100 |
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
9,04071E-06 |
0,000315196 |
| GO:0010810 |
regulation of cell-substrate adhesion |
9,29189E-06 |
0,000317996 |
| GO:0010812 |
negative regulation of cell-substrate adhesion |
9,51252E-06 |
0,000317996 |
| GO:0033627 |
cell adhesion mediated by integrin |
9,51252E-06 |
0,000317996 |
| GO:0055123 |
digestive system development |
9,52194E-06 |
0,000317996 |
| GO:0001667 |
ameboidal-type cell migration |
9,8759E-06 |
0,000322505 |
| GO:0034329 |
cell junction assembly |
9,96191E-06 |
0,000322505 |
| GO:0090092 |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
9,96191E-06 |
0,000322505 |
| GO:0007223 |
Wnt signaling pathway, calcium modulating pathway |
1,02015E-05 |
0,000326925 |
| GO:1904029 |
regulation of cyclin-dependent protein kinase activity |
1,08657E-05 |
0,00034473 |
| GO:0009267 |
cellular response to starvation |
1,1875E-05 |
0,000369895 |
| GO:0045927 |
positive regulation of growth |
1,18921E-05 |
0,000369895 |
| GO:0043217 |
myelin maintenance |
1,25106E-05 |
0,000385356 |
| GO:0061005 |
cell differentiation involved in kidney development |
1,28059E-05 |
0,000390659 |
| GO:0010975 |
regulation of neuron projection development |
1,32253E-05 |
0,000395839 |
| GO:0031667 |
response to nutrient levels |
1,32253E-05 |
0,000395839 |
| GO:0097306 |
cellular response to alcohol |
1,35045E-05 |
0,000399138 |
| GO:0031589 |
cell-substrate adhesion |
1,35871E-05 |
0,000399138 |
| GO:0061180 |
mammary gland epithelium development |
1,5292E-05 |
0,0004451 |
| GO:0034250 |
positive regulation of cellular amide metabolic process |
1,58003E-05 |
0,000455715 |
| GO:0030099 |
myeloid cell differentiation |
1,65214E-05 |
0,00047222 |
| GO:0043488 |
regulation of mRNA stability |
1,69467E-05 |
0,00048005 |
| GO:0031100 |
animal organ regeneration |
1,71325E-05 |
0,00048102 |
| GO:0060644 |
mammary gland epithelial cell differentiation |
1,74274E-05 |
0,000485005 |
| GO:0060968 |
regulation of gene silencing |
1,81594E-05 |
0,000500983 |
| GO:1903034 |
regulation of response to wounding |
1,9234E-05 |
0,000526056 |
| GO:0048565 |
digestive tract development |
1,97554E-05 |
0,000535697 |
| GO:0060964 |
regulation of gene silencing by miRNA |
2,00104E-05 |
0,000538013 |
| GO:0070482 |
response to oxygen levels |
2,16883E-05 |
0,000578225 |
| GO:0060411 |
cardiac septum morphogenesis |
2,38258E-05 |
0,000629921 |
| GO:0006401 |
RNA catabolic process |
2,43482E-05 |
0,000638412 |
| GO:0043487 |
regulation of RNA stability |
2,46384E-05 |
0,000640725 |
| GO:0032535 |
regulation of cellular component size |
2,62265E-05 |
0,000675467 |
| GO:0030219 |
megakaryocyte differentiation |
2,64001E-05 |
0,000675467 |
| GO:0060147 |
regulation of posttranscriptional gene silencing |
2,77715E-05 |
0,000691086 |
| GO:0060966 |
regulation of gene silencing by RNA |
2,77715E-05 |
0,000691086 |
| GO:0003197 |
endocardial cushion development |
2,78819E-05 |
0,000691086 |
| GO:0010463 |
mesenchymal cell proliferation |
2,78819E-05 |
0,000691086 |
| GO:1902808 |
positive regulation of cell cycle G1/S phase transition |
2,83091E-05 |
0,000696235 |
| GO:0009612 |
response to mechanical stimulus |
2,85477E-05 |
0,000696703 |
| GO:0031960 |
response to corticosteroid |
2,90263E-05 |
0,000702974 |
| GO:0003159 |
morphogenesis of an endothelium |
3,1664E-05 |
0,000755324 |
| GO:0061154 |
endothelial tube morphogenesis |
3,1664E-05 |
0,000755324 |
| GO:0003170 |
heart valve development |
3,20092E-05 |
0,000757862 |
| GO:0010632 |
regulation of epithelial cell migration |
3,23883E-05 |
0,000760938 |
| GO:0045652 |
regulation of megakaryocyte differentiation |
3,26188E-05 |
0,000760938 |
| GO:0090287 |
regulation of cellular response to growth factor stimulus |
3,38829E-05 |
0,000784656 |
| GO:2001242 |
regulation of intrinsic apoptotic signaling pathway |
3,52005E-05 |
0,000809263 |
| GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process |
3,75124E-05 |
0,000852154 |
| GO:0033628 |
regulation of cell adhesion mediated by integrin |
3,76033E-05 |
0,000852154 |
| GO:0048511 |
rhythmic process |
3,87413E-05 |
0,000871716 |
| GO:0031668 |
cellular response to extracellular stimulus |
3,90211E-05 |
0,000871828 |
| GO:0042594 |
response to starvation |
3,958E-05 |
0,000878131 |
| GO:0045165 |
cell fate commitment |
4,28392E-05 |
0,000943841 |
| GO:0051896 |
regulation of protein kinase B signaling |
4,4159E-05 |
0,000964241 |
| GO:1901654 |
response to ketone |
4,4373E-05 |
0,000964241 |
| GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity |
4,47403E-05 |
0,000965608 |
| GO:0060135 |
maternal process involved in female pregnancy |
4,56183E-05 |
0,000977905 |
| GO:1901653 |
cellular response to peptide |
4,6787E-05 |
0,000993763 |
| GO:0032868 |
response to insulin |
4,69845E-05 |
0,000993763 |
| GO:0030513 |
positive regulation of BMP signaling pathway |
4,82391E-05 |
0,001012212 |
| GO:0048145 |
regulation of fibroblast proliferation |
4,84948E-05 |
0,001012212 |
| GO:0033629 |
negative regulation of cell adhesion mediated by integrin |
5,0291E-05 |
0,001042843 |
| GO:0003205 |
cardiac chamber development |
5,10644E-05 |
0,001052003 |
| GO:0032970 |
regulation of actin filament-based process |
5,23138E-05 |
0,001069101 |
| GO:0046822 |
regulation of nucleocytoplasmic transport |
5,28812E-05 |
0,001069101 |
| GO:0035148 |
tube formation |
5,29829E-05 |
0,001069101 |
| GO:0048144 |
fibroblast proliferation |
5,33511E-05 |
0,001069101 |
| GO:0003283 |
atrial septum development |
5,35792E-05 |
0,001069101 |
| GO:0071214 |
cellular response to abiotic stimulus |
5,43982E-05 |
0,001071959 |
| GO:0104004 |
cellular response to environmental stimulus |
5,43982E-05 |
0,001071959 |
| GO:0009749 |
response to glucose |
5,55043E-05 |
0,001087005 |
| GO:0071560 |
cellular response to transforming growth factor beta stimulus |
5,62863E-05 |
0,001095557 |
| GO:0007009 |
plasma membrane organization |
5,74038E-05 |
0,001100415 |
| GO:0008593 |
regulation of Notch signaling pathway |
5,74038E-05 |
0,001100415 |
| GO:0060795 |
cell fate commitment involved in formation of primary germ layer |
5,75765E-05 |
0,001100415 |
| GO:0060541 |
respiratory system development |
5,86417E-05 |
0,001114063 |
| GO:1901989 |
positive regulation of cell cycle phase transition |
6,22515E-05 |
0,001175602 |
| GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle |
6,54273E-05 |
0,001228265 |
| GO:0003230 |
cardiac atrium development |
6,83034E-05 |
0,001260129 |
| GO:0110111 |
negative regulation of animal organ morphogenesis |
6,83034E-05 |
0,001260129 |
| GO:0003206 |
cardiac chamber morphogenesis |
6,84983E-05 |
0,001260129 |
| GO:0051897 |
positive regulation of protein kinase B signaling |
6,87134E-05 |
0,001260129 |
| GO:0009746 |
response to hexose |
7,27928E-05 |
0,001327269 |
| GO:0003231 |
cardiac ventricle development |
7,34864E-05 |
0,001330309 |
| GO:0003337 |
mesenchymal to epithelial transition involved in metanephros morphogenesis |
7,42232E-05 |
0,001330309 |
| GO:0048146 |
positive regulation of fibroblast proliferation |
7,45211E-05 |
0,001330309 |
| GO:0071559 |
response to transforming growth factor beta |
7,46368E-05 |
0,001330309 |
| GO:0030278 |
regulation of ossification |
7,67641E-05 |
0,001351982 |
| GO:0034249 |
negative regulation of cellular amide metabolic process |
7,70603E-05 |
0,001351982 |
| GO:0050821 |
protein stabilization |
7,71311E-05 |
0,001351982 |
| GO:0072009 |
nephron epithelium development |
7,89373E-05 |
0,001376038 |
| GO:0031647 |
regulation of protein stability |
8,01636E-05 |
0,001387976 |
| GO:0035265 |
organ growth |
8,09228E-05 |
0,001387976 |
| GO:0009743 |
response to carbohydrate |
8,09345E-05 |
0,001387976 |
| GO:0048771 |
tissue remodeling |
8,16652E-05 |
0,001392977 |
| GO:0003158 |
endothelium development |
8,44015E-05 |
0,001412996 |
| GO:0042552 |
myelination |
8,44015E-05 |
0,001412996 |
| GO:0003179 |
heart valve morphogenesis |
8,46204E-05 |
0,001412996 |
| GO:0072132 |
mesenchyme morphogenesis |
8,46204E-05 |
0,001412996 |
| GO:0097150 |
neuronal stem cell population maintenance |
8,56706E-05 |
0,001423043 |
| GO:0003007 |
heart morphogenesis |
8,96146E-05 |
0,001480803 |
| GO:1903035 |
negative regulation of response to wounding |
9,19399E-05 |
0,001511355 |
| GO:1905314 |
semi-lunar valve development |
9,45204E-05 |
0,001539104 |
| GO:0034284 |
response to monosaccharide |
9,45982E-05 |
0,001539104 |
| GO:0007272 |
ensheathment of neurons |
9,66741E-05 |
0,001549047 |
| GO:0008366 |
axon ensheathment |
9,66741E-05 |
0,001549047 |
| GO:0032355 |
response to estradiol |
9,66741E-05 |
0,001549047 |
| GO:0051091 |
positive regulation of DNA-binding transcription factor activity |
9,80463E-05 |
0,00156314 |
| GO:0097193 |
intrinsic apoptotic signaling pathway |
9,91916E-05 |
0,001566374 |
| GO:0003279 |
cardiac septum development |
9,92742E-05 |
0,001566374 |
| GO:0050900 |
leukocyte migration |
9,98379E-05 |
0,001566374 |
| GO:1901992 |
positive regulation of mitotic cell cycle phase transition |
0,000100224 |
0,001566374 |
| GO:0009755 |
hormone-mediated signaling pathway |
0,000102971 |
0,00160142 |
| GO:0017148 |
negative regulation of translation |
0,000104794 |
0,001621812 |
| GO:0001783 |
B cell apoptotic process |
0,000106414 |
0,001630975 |
| GO:0003181 |
atrioventricular valve morphogenesis |
0,000106414 |
0,001630975 |
| GO:0046661 |
male sex differentiation |
0,000112423 |
0,00171479 |
| GO:0050708 |
regulation of protein secretion |
0,000114711 |
0,001741316 |
| GO:0002011 |
morphogenesis of an epithelial sheet |
0,000121797 |
0,001840086 |
| GO:2000116 |
regulation of cysteine-type endopeptidase activity |
0,000124201 |
0,001867513 |
| GO:0008584 |
male gonad development |
0,000125842 |
0,001883259 |
| GO:0050714 |
positive regulation of protein secretion |
0,00013328 |
0,001980398 |
| GO:0031333 |
negative regulation of protein complex assembly |
0,000134206 |
0,001980398 |
| GO:0046546 |
development of primary male sexual characteristics |
0,000134206 |
0,001980398 |
| GO:0043491 |
protein kinase B signaling |
0,000139123 |
0,002043452 |
| GO:0003281 |
ventricular septum development |
0,000143111 |
0,002092348 |
| GO:0002066 |
columnar/cuboidal epithelial cell development |
0,000153237 |
0,002230114 |
| GO:0008406 |
gonad development |
0,00015572 |
0,002255596 |
| GO:0048844 |
artery morphogenesis |
0,000157145 |
0,002255596 |
| GO:0045787 |
positive regulation of cell cycle |
0,00015726 |
0,002255596 |
| GO:0006979 |
response to oxidative stress |
0,000158646 |
0,002255596 |
| GO:0003171 |
atrioventricular valve development |
0,000159254 |
0,002255596 |
| GO:1903959 |
regulation of anion transmembrane transport |
0,000159254 |
0,002255596 |
| GO:0072006 |
nephron development |
0,000162192 |
0,002276492 |
| GO:0001657 |
ureteric bud development |
0,000164185 |
0,002276492 |
| GO:0048709 |
oligodendrocyte differentiation |
0,000164185 |
0,002276492 |
| GO:0061448 |
connective tissue development |
0,000164789 |
0,002276492 |
| GO:0007565 |
female pregnancy |
0,00016526 |
0,002276492 |
| GO:0016049 |
cell growth |
0,000165752 |
0,002276492 |
| GO:0022604 |
regulation of cell morphogenesis |
0,000165752 |
0,002276492 |
| GO:0010948 |
negative regulation of cell cycle process |
0,000169637 |
0,002319815 |
| GO:0043403 |
skeletal muscle tissue regeneration |
0,000170673 |
0,002323573 |
| GO:0009952 |
anterior/posterior pattern specification |
0,000171377 |
0,002323573 |
| GO:0044344 |
cellular response to fibroblast growth factor stimulus |
0,000172558 |
0,002329156 |
| GO:0050657 |
nucleic acid transport |
0,000173991 |
0,002329156 |
| GO:0050658 |
RNA transport |
0,000173991 |
0,002329156 |
| GO:0072163 |
mesonephric epithelium development |
0,00017759 |
0,00235744 |
| GO:0072164 |
mesonephric tubule development |
0,00017759 |
0,00235744 |
| GO:0051168 |
nuclear export |
0,000183115 |
0,002420657 |
| GO:1901991 |
negative regulation of mitotic cell cycle phase transition |
0,000186357 |
0,002442535 |
| GO:0071902 |
positive regulation of protein serine/threonine kinase activity |
0,000187439 |
0,002442535 |
| GO:0030307 |
positive regulation of cell growth |
0,000188363 |
0,002442535 |
| GO:0048660 |
regulation of smooth muscle cell proliferation |
0,000188363 |
0,002442535 |
| GO:0031016 |
pancreas development |
0,00018862 |
0,002442535 |
| GO:0031102 |
neuron projection regeneration |
0,000190945 |
0,002462595 |
| GO:0001711 |
endodermal cell fate commitment |
0,00019497 |
0,002493891 |
| GO:0072283 |
metanephric renal vesicle morphogenesis |
0,00019497 |
0,002493891 |
| GO:0031641 |
regulation of myelination |
0,00019573 |
0,002493891 |
| GO:0051236 |
establishment of RNA localization |
0,000202602 |
0,002571129 |
| GO:0071260 |
cellular response to mechanical stimulus |
0,000206197 |
0,002597617 |
| GO:0045137 |
development of primary sexual characteristics |
0,000206809 |
0,002597617 |
| GO:0060840 |
artery development |
0,000207146 |
0,002597617 |
| GO:0010634 |
positive regulation of epithelial cell migration |
0,000210186 |
0,00261507 |
| GO:0048659 |
smooth muscle cell proliferation |
0,000210186 |
0,00261507 |
| GO:0045930 |
negative regulation of mitotic cell cycle |
0,000216903 |
0,002688094 |
| GO:0071236 |
cellular response to antibiotic |
0,000219835 |
0,002713829 |
| GO:0030324 |
lung development |
0,000221882 |
0,002728489 |
| GO:0021762 |
substantia nigra development |
0,000223601 |
0,002739004 |
| GO:0033598 |
mammary gland epithelial cell proliferation |
0,000230093 |
0,002793364 |
| GO:0048679 |
regulation of axon regeneration |
0,000230093 |
0,002793364 |
| GO:0014013 |
regulation of gliogenesis |
0,00023068 |
0,002793364 |
| GO:0036293 |
response to decreased oxygen levels |
0,00023204 |
0,002799159 |
| GO:0014065 |
phosphatidylinositol 3-kinase signaling |
0,000233231 |
0,002802868 |
| GO:0007179 |
transforming growth factor beta receptor signaling pathway |
0,000235158 |
0,002815353 |
| GO:0001823 |
mesonephros development |
0,000240679 |
0,002870626 |
| GO:0016579 |
protein deubiquitination |
0,000247732 |
0,002943674 |
| GO:0060412 |
ventricular septum morphogenesis |
0,000254503 |
0,002983562 |
| GO:0021542 |
dentate gyrus development |
0,00025579 |
0,002983562 |
| GO:0033631 |
cell-cell adhesion mediated by integrin |
0,00025579 |
0,002983562 |
| GO:0060413 |
atrial septum morphogenesis |
0,00025579 |
0,002983562 |
| GO:1990000 |
amyloid fibril formation |
0,00025579 |
0,002983562 |
| GO:0032956 |
regulation of actin cytoskeleton organization |
0,000259366 |
0,003002021 |
| GO:0046824 |
positive regulation of nucleocytoplasmic transport |
0,00026123 |
0,003002021 |
| GO:0048857 |
neural nucleus development |
0,00026123 |
0,003002021 |
| GO:0035567 |
non-canonical Wnt signaling pathway |
0,000262104 |
0,003002021 |
| GO:0071774 |
response to fibroblast growth factor |
0,000262104 |
0,003002021 |
| GO:0043434 |
response to peptide hormone |
0,000264387 |
0,003009533 |
| GO:0002791 |
regulation of peptide secretion |
0,000264657 |
0,003009533 |
| GO:0048730 |
epidermis morphogenesis |
0,000273411 |
0,003086853 |
| GO:0030323 |
respiratory tube development |
0,000274376 |
0,003086853 |
| GO:0050796 |
regulation of insulin secretion |
0,000274376 |
0,003086853 |
| GO:2001233 |
regulation of apoptotic signaling pathway |
0,000275759 |
0,003091457 |
| GO:0006403 |
RNA localization |
0,000284102 |
0,003162635 |
| GO:2001234 |
negative regulation of apoptotic signaling pathway |
0,000284102 |
0,003162635 |
| GO:0031571 |
mitotic G1 DNA damage checkpoint |
0,000288805 |
0,00317049 |
| GO:0044819 |
mitotic G1/S transition checkpoint |
0,000288805 |
0,00317049 |
| GO:0046622 |
positive regulation of organ growth |
0,000288805 |
0,00317049 |
| GO:1904377 |
positive regulation of protein localization to cell periphery |
0,000288805 |
0,00317049 |
| GO:0051028 |
mRNA transport |
0,000293937 |
0,003215707 |
| GO:0002793 |
positive regulation of peptide secretion |
0,000301335 |
0,003285307 |
| GO:0007517 |
muscle organ development |
0,000313011 |
0,003385113 |
| GO:0000377 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
0,00031369 |
0,003385113 |
| GO:0000398 |
mRNA splicing, via spliceosome |
0,00031369 |
0,003385113 |
| GO:0044783 |
G1 DNA damage checkpoint |
0,00031867 |
0,003412475 |
| GO:0048736 |
appendage development |
0,000320354 |
0,003412475 |
| GO:0060173 |
limb development |
0,000320354 |
0,003412475 |
| GO:0003209 |
cardiac atrium morphogenesis |
0,000322647 |
0,003412475 |
| GO:1904837 |
beta-catenin-TCF complex assembly |
0,000322647 |
0,003412475 |
| GO:0097305 |
response to alcohol |
0,000324143 |
0,003412475 |
| GO:0035196 |
production of miRNAs involved in gene silencing by miRNA |
0,000326326 |
0,003412475 |
| GO:0003184 |
pulmonary valve morphogenesis |
0,000329133 |
0,003412475 |
| GO:0035313 |
wound healing, spreading of epidermal cells |
0,000329133 |
0,003412475 |
| GO:0045725 |
positive regulation of glycogen biosynthetic process |
0,000329133 |
0,003412475 |
| GO:0061323 |
cell proliferation involved in heart morphogenesis |
0,000329133 |
0,003412475 |
| GO:2000136 |
regulation of cell proliferation involved in heart morphogenesis |
0,000329133 |
0,003412475 |
| GO:1901990 |
regulation of mitotic cell cycle phase transition |
0,000336923 |
0,003481868 |
| GO:0010631 |
epithelial cell migration |
0,000342418 |
0,003527161 |
| GO:0030330 |
DNA damage response, signal transduction by p53 class mediator |
0,000344647 |
0,003527454 |
| GO:0030073 |
insulin secretion |
0,00034467 |
0,003527454 |
| GO:0000375 |
RNA splicing, via transesterification reactions |
0,000345984 |
0,003529514 |
| GO:0060560 |
developmental growth involved in morphogenesis |
0,000353444 |
0,003594061 |
| GO:0016311 |
dephosphorylation |
0,000355812 |
0,003601443 |
| GO:0045765 |
regulation of angiogenesis |
0,000357373 |
0,003601443 |
| GO:0007389 |
pattern specification process |
0,000357575 |
0,003601443 |
| GO:0090276 |
regulation of peptide hormone secretion |
0,000361009 |
0,003624521 |
| GO:0030098 |
lymphocyte differentiation |
0,000366477 |
0,003654485 |
| GO:0030856 |
regulation of epithelial cell differentiation |
0,000367449 |
0,003654485 |
| GO:0045216 |
cell-cell junction organization |
0,000367449 |
0,003654485 |
| GO:0071156 |
regulation of cell cycle arrest |
0,000369342 |
0,003661834 |
| GO:0071229 |
cellular response to acid chemical |
0,000378003 |
0,00370024 |
| GO:0044319 |
wound healing, spreading of cells |
0,000378311 |
0,00370024 |
| GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity |
0,000378311 |
0,00370024 |
| GO:0090505 |
epiboly involved in wound healing |
0,000378311 |
0,00370024 |
| GO:0090132 |
epithelium migration |
0,000379048 |
0,00370024 |
| GO:0030518 |
intracellular steroid hormone receptor signaling pathway |
0,000382129 |
0,003718875 |
| GO:0032872 |
regulation of stress-activated MAPK cascade |
0,000384982 |
0,003731933 |
| GO:1904888 |
cranial skeletal system development |
0,000385823 |
0,003731933 |
| GO:1901988 |
negative regulation of cell cycle phase transition |
0,000410606 |
0,003920051 |
| GO:0048639 |
positive regulation of developmental growth |
0,000411482 |
0,003920051 |
| GO:0008038 |
neuron recognition |
0,000413124 |
0,003920051 |
| GO:0007221 |
positive regulation of transcription of Notch receptor target |
0,000416392 |
0,003920051 |
| GO:0031998 |
regulation of fatty acid beta-oxidation |
0,000416392 |
0,003920051 |
| GO:0060749 |
mammary gland alveolus development |
0,000416392 |
0,003920051 |
| GO:0061377 |
mammary gland lobule development |
0,000416392 |
0,003920051 |
| GO:0070875 |
positive regulation of glycogen metabolic process |
0,000416392 |
0,003920051 |
| GO:0072077 |
renal vesicle morphogenesis |
0,000416392 |
0,003920051 |
| GO:0070302 |
regulation of stress-activated protein kinase signaling cascade |
0,000418896 |
0,00393196 |
| GO:0046677 |
response to antibiotic |
0,000425404 |
0,003981266 |
| GO:0090068 |
positive regulation of cell cycle process |
0,000439212 |
0,004043112 |
| GO:0003176 |
aortic valve development |
0,000440933 |
0,004043112 |
| GO:0003338 |
metanephros morphogenesis |
0,000440933 |
0,004043112 |
| GO:0060317 |
cardiac epithelial to mesenchymal transition |
0,000440933 |
0,004043112 |
| GO:0060674 |
placenta blood vessel development |
0,000440933 |
0,004043112 |
| GO:0070570 |
regulation of neuron projection regeneration |
0,000440933 |
0,004043112 |
| GO:0090504 |
epiboly |
0,000440933 |
0,004043112 |
| GO:0014706 |
striated muscle tissue development |
0,000446646 |
0,0040837 |
| GO:0070646 |
protein modification by small protein removal |
0,000455593 |
0,004153529 |
| GO:0001889 |
liver development |
0,000456977 |
0,004154211 |
| GO:0007548 |
sex differentiation |
0,000461632 |
0,004171106 |
| GO:0090130 |
tissue migration |
0,000462616 |
0,004171106 |
| GO:0008347 |
glial cell migration |
0,00046278 |
0,004171106 |
| GO:0001656 |
metanephros development |
0,00050459 |
0,004535065 |
| GO:0070227 |
lymphocyte apoptotic process |
0,000507306 |
0,004539325 |
| GO:0034599 |
cellular response to oxidative stress |
0,000507925 |
0,004539325 |
| GO:0046620 |
regulation of organ growth |
0,000515738 |
0,00459562 |
| GO:0032869 |
cellular response to insulin stimulus |
0,000517122 |
0,00459562 |
| GO:0072087 |
renal vesicle development |
0,000518986 |
0,004599303 |
| GO:0048568 |
embryonic organ development |
0,000540469 |
0,004776347 |
| GO:0061008 |
hepaticobiliary system development |
0,000543616 |
0,004790813 |
| GO:0008543 |
fibroblast growth factor receptor signaling pathway |
0,000550073 |
0,004820938 |
| GO:0045446 |
endothelial cell differentiation |
0,000550073 |
0,004820938 |
| GO:0031050 |
dsRNA processing |
0,000575956 |
0,005006295 |
| GO:0031103 |
axon regeneration |
0,000575956 |
0,005006295 |
| GO:0070918 |
production of small RNA involved in gene silencing by RNA |
0,000575956 |
0,005006295 |
| GO:1904375 |
regulation of protein localization to cell periphery |
0,000586259 |
0,005081925 |
| GO:0051090 |
regulation of DNA-binding transcription factor activity |
0,000607108 |
0,005237252 |
| GO:0007015 |
actin filament organization |
0,00060748 |
0,005237252 |
| GO:0072080 |
nephron tubule development |
0,000628824 |
0,005391962 |
| GO:1901655 |
cellular response to ketone |
0,000628824 |
0,005391962 |
| GO:0003215 |
cardiac right ventricle morphogenesis |
0,000638353 |
0,00544403 |
| GO:0032495 |
response to muramyl dipeptide |
0,000638353 |
0,00544403 |
| GO:1902373 |
negative regulation of mRNA catabolic process |
0,000640044 |
0,00544403 |
| GO:0030072 |
peptide hormone secretion |
0,000654592 |
0,005552886 |
| GO:0045666 |
positive regulation of neuron differentiation |
0,000657705 |
0,005564412 |
| GO:0044706 |
multi-multicellular organism process |
0,000668754 |
0,005600282 |
| GO:0042326 |
negative regulation of phosphorylation |
0,000668881 |
0,005600282 |
| GO:0042113 |
B cell activation |
0,000673389 |
0,005600282 |
| GO:0060993 |
kidney morphogenesis |
0,000675326 |
0,005600282 |
| GO:0001893 |
maternal placenta development |
0,000676066 |
0,005600282 |
| GO:0003203 |
endocardial cushion morphogenesis |
0,000676066 |
0,005600282 |
| GO:0006369 |
termination of RNA polymerase II transcription |
0,000676066 |
0,005600282 |
| GO:0035909 |
aorta morphogenesis |
0,000676066 |
0,005600282 |
| GO:0008380 |
RNA splicing |
0,000687383 |
0,005679204 |
| GO:0010976 |
positive regulation of neuron projection development |
0,000697844 |
0,005750653 |
| GO:0051098 |
regulation of binding |
0,000699896 |
0,005752625 |
| GO:0060563 |
neuroepithelial cell differentiation |
0,000709521 |
0,005816661 |
| GO:0003208 |
cardiac ventricle morphogenesis |
0,000714658 |
0,005828654 |
| GO:0043627 |
response to estrogen |
0,000714658 |
0,005828654 |
| GO:0010256 |
endomembrane system organization |
0,000720383 |
0,00585204 |
| GO:0060538 |
skeletal muscle organ development |
0,000721214 |
0,00585204 |
| GO:0061326 |
renal tubule development |
0,000724562 |
0,005864202 |
| GO:0001649 |
osteoblast differentiation |
0,000757642 |
0,006100811 |
| GO:0007160 |
cell-matrix adhesion |
0,000757642 |
0,006100811 |
| GO:0060537 |
muscle tissue development |
0,000770039 |
0,00618494 |
| GO:0051973 |
positive regulation of telomerase activity |
0,000772114 |
0,006185945 |
| GO:0045747 |
positive regulation of Notch signaling pathway |
0,00078469 |
0,006255103 |
| GO:0050994 |
regulation of lipid catabolic process |
0,00078469 |
0,006255103 |
| GO:0072089 |
stem cell proliferation |
0,000797635 |
0,00631852 |
| GO:0031098 |
stress-activated protein kinase signaling cascade |
0,00079862 |
0,00631852 |
| GO:0051961 |
negative regulation of nervous system development |
0,00079862 |
0,00631852 |
| GO:0048638 |
regulation of developmental growth |
0,000827854 |
0,006533521 |
| GO:0044773 |
mitotic DNA damage checkpoint |
0,000831699 |
0,006547577 |
| GO:0051403 |
stress-activated MAPK cascade |
0,000835282 |
0,006559511 |
| GO:0006353 |
DNA-templated transcription, termination |
0,000840851 |
0,006572888 |
| GO:0042542 |
response to hydrogen peroxide |
0,000843201 |
0,006572888 |
| GO:0051384 |
response to glucocorticoid |
0,000843201 |
0,006572888 |
| GO:0048863 |
stem cell differentiation |
0,000856736 |
0,006662026 |
| GO:2000142 |
regulation of DNA-templated transcription, initiation |
0,000877988 |
0,006810595 |
| GO:0003183 |
mitral valve morphogenesis |
0,000909455 |
0,007003312 |
| GO:0007440 |
foregut morphogenesis |
0,000909455 |
0,007003312 |
| GO:0098734 |
macromolecule depalmitoylation |
0,000909455 |
0,007003312 |
| GO:1901987 |
regulation of cell cycle phase transition |
0,000922053 |
0,007083136 |
| GO:1904018 |
positive regulation of vasculature development |
0,000927834 |
0,007110324 |
| GO:0002052 |
positive regulation of neuroblast proliferation |
0,000933229 |
0,007134435 |
| GO:0031346 |
positive regulation of cell projection organization |
0,000947534 |
0,007226387 |
| GO:0001708 |
cell fate specification |
0,0009512 |
0,007235945 |
| GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
0,000953349 |
0,007235945 |
| GO:0048678 |
response to axon injury |
0,000984004 |
0,007446319 |
| GO:0050773 |
regulation of dendrite development |
0,00098576 |
0,007446319 |
| GO:0000302 |
response to reactive oxygen species |
0,001004346 |
0,007561612 |
| GO:0007043 |
cell-cell junction assembly |
0,001008173 |
0,007561612 |
| GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling |
0,001008173 |
0,007561612 |
| GO:0045766 |
positive regulation of angiogenesis |
0,001024828 |
0,007668401 |
| GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint |
0,00104748 |
0,007801097 |
| GO:1902400 |
intracellular signal transduction involved in G1 DNA damage checkpoint |
0,00104748 |
0,007801097 |
| GO:0071157 |
negative regulation of cell cycle arrest |
0,001111662 |
0,008240405 |
| GO:0072215 |
regulation of metanephros development |
0,001111662 |
0,008240405 |
| GO:0048713 |
regulation of oligodendrocyte differentiation |
0,001121672 |
0,008275938 |
| GO:2000648 |
positive regulation of stem cell proliferation |
0,001121672 |
0,008275938 |
| GO:0050768 |
negative regulation of neurogenesis |
0,001140737 |
0,00836906 |
| GO:1901342 |
regulation of vasculature development |
0,001145214 |
0,00836906 |
| GO:1903312 |
negative regulation of mRNA metabolic process |
0,001145666 |
0,00836906 |
| GO:0001890 |
placenta development |
0,001147492 |
0,00836906 |
| GO:0035904 |
aorta development |
0,001148583 |
0,00836906 |
| GO:0006611 |
protein export from nucleus |
0,001155397 |
0,00836906 |
| GO:0008361 |
regulation of cell size |
0,001155397 |
0,00836906 |
| GO:0051099 |
positive regulation of binding |
0,001155397 |
0,00836906 |
| GO:0045727 |
positive regulation of translation |
0,001193932 |
0,008628487 |
| GO:0001666 |
response to hypoxia |
0,00119949 |
0,008648954 |
| GO:1905330 |
regulation of morphogenesis of an epithelium |
0,001208661 |
0,008694273 |
| GO:0007623 |
circadian rhythm |
0,001211256 |
0,008694273 |
| GO:0002328 |
pro-B cell differentiation |
0,001231641 |
0,008761307 |
| GO:0003174 |
mitral valve development |
0,001231641 |
0,008761307 |
| GO:0033632 |
regulation of cell-cell adhesion mediated by integrin |
0,001231641 |
0,008761307 |
| GO:0061314 |
Notch signaling involved in heart development |
0,001231641 |
0,008761307 |
| GO:0072413 |
signal transduction involved in mitotic cell cycle checkpoint |
0,001256995 |
0,008793825 |
| GO:1902369 |
negative regulation of RNA catabolic process |
0,001256995 |
0,008793825 |
| GO:1902402 |
signal transduction involved in mitotic DNA damage checkpoint |
0,001256995 |
0,008793825 |
| GO:1902403 |
signal transduction involved in mitotic DNA integrity checkpoint |
0,001256995 |
0,008793825 |
| GO:0098760 |
response to interleukin-7 |
0,001260737 |
0,008793825 |
| GO:0098761 |
cellular response to interleukin-7 |
0,001260737 |
0,008793825 |
| GO:2000008 |
regulation of protein localization to cell surface |
0,001260737 |
0,008793825 |
| GO:0008154 |
actin polymerization or depolymerization |
0,001262012 |
0,008793825 |
| GO:0022408 |
negative regulation of cell-cell adhesion |
0,00126393 |
0,008793825 |
| GO:0048015 |
phosphatidylinositol-mediated signaling |
0,00126393 |
0,008793825 |
| GO:0010770 |
positive regulation of cell morphogenesis involved in differentiation |
0,00126689 |
0,008795129 |
| GO:0031331 |
positive regulation of cellular catabolic process |
0,001273472 |
0,008821521 |
| GO:0031334 |
positive regulation of protein complex assembly |
0,001279632 |
0,008844885 |
| GO:0071887 |
leukocyte apoptotic process |
0,001310768 |
0,00901461 |
| GO:0001654 |
eye development |
0,00131189 |
0,00901461 |
| GO:0003272 |
endocardial cushion formation |
0,001312711 |
0,00901461 |
| GO:0030041 |
actin filament polymerization |
0,00132126 |
0,009037584 |
| GO:0021766 |
hippocampus development |
0,001327451 |
0,009037584 |
| GO:0034109 |
homotypic cell-cell adhesion |
0,001327451 |
0,009037584 |
| GO:0048708 |
astrocyte differentiation |
0,001327451 |
0,009037584 |
| GO:0051047 |
positive regulation of secretion |
0,001348483 |
0,009161112 |
| GO:0021953 |
central nervous system neuron differentiation |
0,00138071 |
0,009360007 |
| GO:0051052 |
regulation of DNA metabolic process |
0,001385184 |
0,009370319 |
| GO:0010769 |
regulation of cell morphogenesis involved in differentiation |
0,001392806 |
0,009401831 |
| GO:0015931 |
nucleobase-containing compound transport |
0,001417176 |
0,009546027 |
| GO:0030279 |
negative regulation of ossification |
0,001426412 |
0,009587878 |
| GO:0048017 |
inositol lipid-mediated signaling |
0,001442337 |
0,009674427 |
| GO:0042110 |
T cell activation |
0,001447356 |
0,009687609 |
| GO:0150063 |
visual system development |
0,001475535 |
0,009855432 |
| GO:0044774 |
mitotic DNA integrity checkpoint |
0,001481765 |
0,009867945 |
| GO:0030183 |
B cell differentiation |
0,001483629 |
0,009867945 |
| GO:1903532 |
positive regulation of secretion by cell |
0,001498696 |
0,009947299 |
| GO:0006970 |
response to osmotic stress |
0,001531036 |
0,010059772 |
| GO:0002068 |
glandular epithelial cell development |
0,001537837 |
0,010059772 |
| GO:0030325 |
adrenal gland development |
0,001537837 |
0,010059772 |
| GO:0031069 |
hair follicle morphogenesis |
0,001537837 |
0,010059772 |
| GO:0048103 |
somatic stem cell division |
0,001537837 |
0,010059772 |
| GO:0072202 |
cell differentiation involved in metanephros development |
0,001537837 |
0,010059772 |
| GO:0072273 |
metanephric nephron morphogenesis |
0,001537837 |
0,010059772 |
| GO:0042476 |
odontogenesis |
0,001564227 |
0,010190383 |
| GO:0072175 |
epithelial tube formation |
0,001564227 |
0,010190383 |
| GO:0010907 |
positive regulation of glucose metabolic process |
0,001576514 |
0,010249382 |
| GO:0021889 |
olfactory bulb interneuron differentiation |
0,001617447 |
0,010430006 |
| GO:0060081 |
membrane hyperpolarization |
0,001617447 |
0,010430006 |
| GO:0060213 |
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
0,001617447 |
0,010430006 |
| GO:0072697 |
protein localization to cell cortex |
0,001617447 |
0,010430006 |
| GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
0,001641544 |
0,010563924 |
| GO:0042770 |
signal transduction in response to DNA damage |
0,001648303 |
0,010585947 |
| GO:2000278 |
regulation of DNA biosynthetic process |
0,001669998 |
0,01067781 |
| GO:0022407 |
regulation of cell-cell adhesion |
0,001672703 |
0,01067781 |
| GO:0045785 |
positive regulation of cell adhesion |
0,001672703 |
0,01067781 |
| GO:0007519 |
skeletal muscle tissue development |
0,001687146 |
0,010748377 |
| GO:0048872 |
homeostasis of number of cells |
0,001701814 |
0,010812684 |
| GO:0048880 |
sensory system development |
0,001704056 |
0,010812684 |
| GO:0050920 |
regulation of chemotaxis |
0,001734969 |
0,010971265 |
| GO:0018210 |
peptidyl-threonine modification |
0,001735964 |
0,010971265 |
| GO:0001953 |
negative regulation of cell-matrix adhesion |
0,001754529 |
0,011022721 |
| GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress |
0,001754529 |
0,011022721 |
| GO:0032459 |
regulation of protein oligomerization |
0,001754529 |
0,011022721 |
| GO:0014031 |
mesenchymal cell development |
0,001758158 |
0,011023689 |
| GO:0034394 |
protein localization to cell surface |
0,001770668 |
0,011080229 |
| GO:0001701 |
in utero embryonic development |
0,001803463 |
0,011263235 |
| GO:0007599 |
hemostasis |
0,001817255 |
0,011327077 |
| GO:0050921 |
positive regulation of chemotaxis |
0,001827321 |
0,01136748 |
| GO:0016569 |
covalent chromatin modification |
0,001859655 |
0,011545986 |
| GO:0043583 |
ear development |
0,001873576 |
0,0116097 |
| GO:0048013 |
ephrin receptor signaling pathway |
0,001881103 |
0,01163362 |
| GO:0045931 |
positive regulation of mitotic cell cycle |
0,001936064 |
0,011950227 |
| GO:0042987 |
amyloid precursor protein catabolic process |
0,00194684 |
0,011993409 |
| GO:0002690 |
positive regulation of leukocyte chemotaxis |
0,00201061 |
0,012362256 |
| GO:0032530 |
regulation of microvillus organization |
0,002071035 |
0,012587413 |
| GO:0048681 |
negative regulation of axon regeneration |
0,002071035 |
0,012587413 |
| GO:0060576 |
intestinal epithelial cell development |
0,002071035 |
0,012587413 |
| GO:0061042 |
vascular wound healing |
0,002071035 |
0,012587413 |
| GO:0061478 |
response to platelet aggregation inhibitor |
0,002071035 |
0,012587413 |
| GO:1903960 |
negative regulation of anion transmembrane transport |
0,002071035 |
0,012587413 |
| GO:2000177 |
regulation of neural precursor cell proliferation |
0,00214691 |
0,01299278 |
| GO:0031018 |
endocrine pancreas development |
0,002154112 |
0,01299278 |
| GO:0048255 |
mRNA stabilization |
0,002154112 |
0,01299278 |
| GO:0070316 |
regulation of G0 to G1 transition |
0,002154112 |
0,01299278 |
| GO:0021700 |
developmental maturation |
0,002196368 |
0,013222517 |
| GO:0033157 |
regulation of intracellular protein transport |
0,002344901 |
0,01406334 |
| GO:0045665 |
negative regulation of neuron differentiation |
0,002344901 |
0,01406334 |
| GO:0042634 |
regulation of hair cycle |
0,002372106 |
0,014148939 |
| GO:0060260 |
regulation of transcription initiation from RNA polymerase II promoter |
0,002372106 |
0,014148939 |
| GO:0002685 |
regulation of leukocyte migration |
0,002374396 |
0,014148939 |
| GO:0002067 |
glandular epithelial cell differentiation |
0,002377012 |
0,014148939 |
| GO:0007611 |
learning or memory |
0,002413815 |
0,014301341 |
| GO:0034614 |
cellular response to reactive oxygen species |
0,002416176 |
0,014301341 |
| GO:1990138 |
neuron projection extension |
0,002416176 |
0,014301341 |
| GO:0003002 |
regionalization |
0,002427923 |
0,014301341 |
| GO:0048662 |
negative regulation of smooth muscle cell proliferation |
0,002429662 |
0,014301341 |
| GO:0060038 |
cardiac muscle cell proliferation |
0,002429662 |
0,014301341 |
| GO:0030901 |
midbrain development |
0,002440836 |
0,014340506 |
| GO:0009411 |
response to UV |
0,002459373 |
0,014422708 |
| GO:0034332 |
adherens junction organization |
0,002579789 |
0,015067604 |
| GO:1902904 |
negative regulation of supramolecular fiber organization |
0,002579789 |
0,015067604 |
| GO:0006470 |
protein dephosphorylation |
0,002594707 |
0,015067604 |
| GO:0071375 |
cellular response to peptide hormone stimulus |
0,002594707 |
0,015067604 |
| GO:0060211 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening |
0,002596232 |
0,015067604 |
| GO:0051054 |
positive regulation of DNA metabolic process |
0,002614518 |
0,015067604 |
| GO:0045023 |
G0 to G1 transition |
0,002616213 |
0,015067604 |
| GO:0061383 |
trabecula morphogenesis |
0,002616213 |
0,015067604 |
| GO:0070849 |
response to epidermal growth factor |
0,002616213 |
0,015067604 |
| GO:0006661 |
phosphatidylinositol biosynthetic process |
0,002619752 |
0,015067604 |
| GO:0016570 |
histone modification |
0,002621583 |
0,015067604 |
| GO:0035966 |
response to topologically incorrect protein |
0,002670901 |
0,015323297 |
| GO:0005979 |
regulation of glycogen biosynthetic process |
0,002707897 |
0,015462601 |
| GO:0010962 |
regulation of glucan biosynthetic process |
0,002707897 |
0,015462601 |
| GO:0010594 |
regulation of endothelial cell migration |
0,002709803 |
0,015462601 |
| GO:1901222 |
regulation of NIK/NF-kappaB signaling |
0,002763258 |
0,015719883 |
| GO:2000117 |
negative regulation of cysteine-type endopeptidase activity |
0,002764801 |
0,015719883 |
| GO:0009896 |
positive regulation of catabolic process |
0,002820538 |
0,015982713 |
| GO:0042698 |
ovulation cycle |
0,002821103 |
0,015982713 |
| GO:0071322 |
cellular response to carbohydrate stimulus |
0,002834625 |
0,016030698 |
| GO:0007595 |
lactation |
0,002872386 |
0,016129243 |
| GO:0030850 |
prostate gland development |
0,002872386 |
0,016129243 |
| GO:0051972 |
regulation of telomerase activity |
0,002872386 |
0,016129243 |
| GO:0060324 |
face development |
0,002872386 |
0,016129243 |
| GO:0051146 |
striated muscle cell differentiation |
0,002915611 |
0,016343036 |
| GO:0032092 |
positive regulation of protein binding |
0,002938659 |
0,016443182 |
| GO:0052548 |
regulation of endopeptidase activity |
0,002964861 |
0,016556196 |
| GO:0000077 |
DNA damage checkpoint |
0,002969294 |
0,016556196 |
| GO:0009615 |
response to virus |
0,003002044 |
0,016709438 |
| GO:0072091 |
regulation of stem cell proliferation |
0,003033648 |
0,016855774 |
| GO:0001952 |
regulation of cell-matrix adhesion |
0,003068633 |
0,0169659 |
| GO:0046320 |
regulation of fatty acid oxidation |
0,003074858 |
0,0169659 |
| GO:0048384 |
retinoic acid receptor signaling pathway |
0,003074858 |
0,0169659 |
| GO:0097421 |
liver regeneration |
0,003074858 |
0,0169659 |
| GO:0016358 |
dendrite development |
0,0031196 |
0,017182887 |
| GO:0048546 |
digestive tract morphogenesis |
0,003146205 |
0,017299392 |
| GO:0050890 |
cognition |
0,003194486 |
0,017365525 |
| GO:0034111 |
negative regulation of homotypic cell-cell adhesion |
0,003196547 |
0,017365525 |
| GO:0042159 |
lipoprotein catabolic process |
0,003196547 |
0,017365525 |
| GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly |
0,003196547 |
0,017365525 |
| GO:0070571 |
negative regulation of neuron projection regeneration |
0,003196547 |
0,017365525 |
| GO:0072075 |
metanephric mesenchyme development |
0,003196547 |
0,017365525 |
| GO:0072148 |
epithelial cell fate commitment |
0,003196547 |
0,017365525 |
| GO:0048588 |
developmental cell growth |
0,003229521 |
0,017462157 |
| GO:0006342 |
chromatin silencing |
0,003230847 |
0,017462157 |
| GO:0017015 |
regulation of transforming growth factor beta receptor signaling pathway |
0,003230847 |
0,017462157 |
| GO:0120032 |
regulation of plasma membrane bounded cell projection assembly |
0,003244193 |
0,01750447 |
| GO:0061351 |
neural precursor cell proliferation |
0,003253764 |
0,017526306 |
| GO:0032984 |
protein-containing complex disassembly |
0,003270787 |
0,017565037 |
| GO:0001933 |
negative regulation of protein phosphorylation |
0,003272027 |
0,017565037 |
| GO:0044070 |
regulation of anion transport |
0,003311374 |
0,017716306 |
| GO:1903076 |
regulation of protein localization to plasma membrane |
0,003311374 |
0,017716306 |
| GO:0046883 |
regulation of hormone secretion |
0,003353912 |
0,017913681 |
| GO:0030968 |
endoplasmic reticulum unfolded protein response |
0,003399646 |
0,018028503 |
| GO:0048675 |
axon extension |
0,003399646 |
0,018028503 |
| GO:0035107 |
appendage morphogenesis |
0,003403822 |
0,018028503 |
| GO:0035108 |
limb morphogenesis |
0,003403822 |
0,018028503 |
| GO:0061041 |
regulation of wound healing |
0,003403822 |
0,018028503 |
| GO:0018205 |
peptidyl-lysine modification |
0,003428847 |
0,018130781 |
| GO:0043489 |
RNA stabilization |
0,003438343 |
0,01815074 |
| GO:0032024 |
positive regulation of insulin secretion |
0,003494335 |
0,018379979 |
| GO:0061035 |
regulation of cartilage development |
0,003494335 |
0,018379979 |
| GO:0090277 |
positive regulation of peptide hormone secretion |
0,003510735 |
0,018379979 |
| GO:1990823 |
response to leukemia inhibitory factor |
0,003510735 |
0,018379979 |
| GO:1990830 |
cellular response to leukemia inhibitory factor |
0,003510735 |
0,018379979 |
| GO:0060491 |
regulation of cell projection assembly |
0,003518138 |
0,018388397 |
| GO:0032102 |
negative regulation of response to external stimulus |
0,003561839 |
0,01858619 |
| GO:1903844 |
regulation of cellular response to transforming growth factor beta stimulus |
0,003575206 |
0,018625309 |
| GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
0,003661832 |
0,019045319 |
| GO:0043255 |
regulation of carbohydrate biosynthetic process |
0,003719104 |
0,019247954 |
| GO:0048754 |
branching morphogenesis of an epithelial tube |
0,003720236 |
0,019247954 |
| GO:0000281 |
mitotic cytokinesis |
0,003743261 |
0,019247954 |
| GO:0045685 |
regulation of glial cell differentiation |
0,003743261 |
0,019247954 |
| GO:0060350 |
endochondral bone morphogenesis |
0,003743261 |
0,019247954 |
| GO:0072401 |
signal transduction involved in DNA integrity checkpoint |
0,003743261 |
0,019247954 |
| GO:0072422 |
signal transduction involved in DNA damage checkpoint |
0,003743261 |
0,019247954 |
| GO:0030336 |
negative regulation of cell migration |
0,003762492 |
0,019315536 |
| GO:0008064 |
regulation of actin polymerization or depolymerization |
0,003810142 |
0,019493186 |
| GO:0048705 |
skeletal system morphogenesis |
0,003827109 |
0,019493186 |
| GO:0002070 |
epithelial cell maturation |
0,003875183 |
0,019493186 |
| GO:0003222 |
ventricular trabecula myocardium morphogenesis |
0,003875183 |
0,019493186 |
| GO:0030033 |
microvillus assembly |
0,003875183 |
0,019493186 |
| GO:0034975 |
protein folding in endoplasmic reticulum |
0,003875183 |
0,019493186 |
| GO:0048820 |
hair follicle maturation |
0,003875183 |
0,019493186 |
| GO:0060965 |
negative regulation of gene silencing by miRNA |
0,003875183 |
0,019493186 |
| GO:0097091 |
synaptic vesicle clustering |
0,003875183 |
0,019493186 |
| GO:0099170 |
postsynaptic modulation of chemical synaptic transmission |
0,003875183 |
0,019493186 |
| GO:1902001 |
fatty acid transmembrane transport |
0,003875183 |
0,019493186 |
| GO:1902004 |
positive regulation of amyloid-beta formation |
0,003875183 |
0,019493186 |
| GO:0051216 |
cartilage development |
0,00388175 |
0,019493186 |
| GO:0046685 |
response to arsenic-containing substance |
0,003907692 |
0,019493186 |
| GO:0051385 |
response to mineralocorticoid |
0,003907692 |
0,019493186 |
| GO:0061311 |
cell surface receptor signaling pathway involved in heart development |
0,003907692 |
0,019493186 |
| GO:0061384 |
heart trabecula morphogenesis |
0,003907692 |
0,019493186 |
| GO:0071353 |
cellular response to interleukin-4 |
0,003907692 |
0,019493186 |
| GO:0001838 |
embryonic epithelial tube formation |
0,003947331 |
0,019660013 |
| GO:0030217 |
T cell differentiation |
0,003956678 |
0,019675677 |
| GO:0030832 |
regulation of actin filament length |
0,00396317 |
0,019677119 |
| GO:0007596 |
blood coagulation |
0,003975407 |
0,019707032 |
| GO:0014015 |
positive regulation of gliogenesis |
0,004005102 |
0,019792388 |
| GO:0072395 |
signal transduction involved in cell cycle checkpoint |
0,004005102 |
0,019792388 |
| GO:0032330 |
regulation of chondrocyte differentiation |
0,004080262 |
0,020070028 |
| GO:0060421 |
positive regulation of heart growth |
0,004080262 |
0,020070028 |
| GO:2000179 |
positive regulation of neural precursor cell proliferation |
0,004080262 |
0,020070028 |
| GO:0042593 |
glucose homeostasis |
0,004089752 |
0,020085569 |
| GO:0030326 |
embryonic limb morphogenesis |
0,004144258 |
0,020290436 |
| GO:0035113 |
embryonic appendage morphogenesis |
0,004144258 |
0,020290436 |
| GO:0043542 |
endothelial cell migration |
0,004174403 |
0,020406539 |
| GO:0033500 |
carbohydrate homeostasis |
0,004226399 |
0,020628935 |
| GO:0018107 |
peptidyl-threonine phosphorylation |
0,00434867 |
0,021193131 |
| GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress |
0,004376193 |
0,021229432 |
| GO:1901186 |
positive regulation of ERBB signaling pathway |
0,004376193 |
0,021229432 |
| GO:1902692 |
regulation of neuroblast proliferation |
0,004376193 |
0,021229432 |
| GO:0009895 |
negative regulation of catabolic process |
0,004537015 |
0,021975996 |
| GO:0061045 |
negative regulation of wound healing |
0,004569115 |
0,022013938 |
| GO:0072088 |
nephron epithelium morphogenesis |
0,004569115 |
0,022013938 |
| GO:0007411 |
axon guidance |
0,004572381 |
0,022013938 |
| GO:0007254 |
JNK cascade |
0,004633211 |
0,022013938 |
| GO:2001020 |
regulation of response to DNA damage stimulus |
0,004633211 |
0,022013938 |
| GO:0003198 |
epithelial to mesenchymal transition involved in endocardial cushion formation |
0,004635051 |
0,022013938 |
| GO:0032460 |
negative regulation of protein oligomerization |
0,004635051 |
0,022013938 |
| GO:0033599 |
regulation of mammary gland epithelial cell proliferation |
0,004635051 |
0,022013938 |
| GO:0035988 |
chondrocyte proliferation |
0,004635051 |
0,022013938 |
| GO:0061318 |
renal filtration cell differentiation |
0,004635051 |
0,022013938 |
| GO:0072112 |
glomerular visceral epithelial cell differentiation |
0,004635051 |
0,022013938 |
| GO:1905331 |
negative regulation of morphogenesis of an epithelium |
0,004635051 |
0,022013938 |
| GO:2000811 |
negative regulation of anoikis |
0,004635051 |
0,022013938 |
| GO:0050817 |
coagulation |
0,004673977 |
0,02216563 |
| GO:0097485 |
neuron projection guidance |
0,004711634 |
0,022310866 |
| GO:0019216 |
regulation of lipid metabolic process |
0,004725819 |
0,022344686 |
| GO:0002576 |
platelet degranulation |
0,004780693 |
0,022503528 |
| GO:0002687 |
positive regulation of leukocyte migration |
0,004780693 |
0,022503528 |
| GO:0034763 |
negative regulation of transmembrane transport |
0,004780693 |
0,022503528 |
| GO:0001101 |
response to acid chemical |
0,004799564 |
0,022540439 |
| GO:0046328 |
regulation of JNK cascade |
0,004802744 |
0,022540439 |
| GO:0034205 |
amyloid-beta formation |
0,00488112 |
0,022773522 |
| GO:0043276 |
anoikis |
0,00488112 |
0,022773522 |
| GO:0070670 |
response to interleukin-4 |
0,00488112 |
0,022773522 |
| GO:0071402 |
cellular response to lipoprotein particle stimulus |
0,00488112 |
0,022773522 |
| GO:2000379 |
positive regulation of reactive oxygen species metabolic process |
0,004905145 |
0,022852008 |
| GO:0010721 |
negative regulation of cell development |
0,004927881 |
0,022924267 |
| GO:0001764 |
neuron migration |
0,005012878 |
0,023251486 |
| GO:0031570 |
DNA integrity checkpoint |
0,005012878 |
0,023251486 |
| GO:0046879 |
hormone secretion |
0,005074699 |
0,023503868 |
| GO:0009314 |
response to radiation |
0,005115271 |
0,023657247 |
| GO:0043543 |
protein acylation |
0,005125152 |
0,02366844 |
| GO:0043393 |
regulation of protein binding |
0,005136766 |
0,023687596 |
| GO:0034766 |
negative regulation of ion transmembrane transport |
0,005173024 |
0,023724124 |
| GO:1905475 |
regulation of protein localization to membrane |
0,005175294 |
0,023724124 |
| GO:0010827 |
regulation of glucose transmembrane transport |
0,005189554 |
0,023724124 |
| GO:0021954 |
central nervous system neuron development |
0,005189554 |
0,023724124 |
| GO:0033143 |
regulation of intracellular steroid hormone receptor signaling pathway |
0,005189554 |
0,023724124 |
| GO:0072028 |
nephron morphogenesis |
0,005189554 |
0,023724124 |
| GO:0003229 |
ventricular cardiac muscle tissue development |
0,005197255 |
0,023725146 |
| GO:0048871 |
multicellular organismal homeostasis |
0,005328893 |
0,024291112 |
| GO:0009416 |
response to light stimulus |
0,005362205 |
0,024372925 |
| GO:0043010 |
camera-type eye development |
0,005362205 |
0,024372925 |
| GO:0021955 |
central nervous system neuron axonogenesis |
0,005423707 |
0,024546969 |
| GO:0070873 |
regulation of glycogen metabolic process |
0,005423707 |
0,024546969 |
| GO:1902991 |
regulation of amyloid precursor protein catabolic process |
0,005423707 |
0,024546969 |
| GO:0001558 |
regulation of cell growth |
0,005447365 |
0,024585801 |
| GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage |
0,005451744 |
0,024585801 |
| GO:0002902 |
regulation of B cell apoptotic process |
0,005478783 |
0,024585801 |
| GO:0045683 |
negative regulation of epidermis development |
0,005478783 |
0,024585801 |
| GO:0072311 |
glomerular epithelial cell differentiation |
0,005478783 |
0,024585801 |
| GO:1900153 |
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
0,005478783 |
0,024585801 |
| GO:0007584 |
response to nutrient |
0,005495854 |
0,02462757 |
| GO:0052547 |
regulation of peptidase activity |
0,005595574 |
0,024907708 |
| GO:2000146 |
negative regulation of cell motility |
0,005611919 |
0,024907708 |
| GO:0022029 |
telencephalon cell migration |
0,005613325 |
0,024907708 |
| GO:0060688 |
regulation of morphogenesis of a branching structure |
0,005613325 |
0,024907708 |
| GO:0090183 |
regulation of kidney development |
0,005613325 |
0,024907708 |
| GO:0098586 |
cellular response to virus |
0,005613325 |
0,024907708 |
| GO:1903078 |
positive regulation of protein localization to plasma membrane |
0,005613325 |
0,024907708 |
| GO:0021915 |
neural tube development |
0,005663306 |
0,02509439 |
| GO:0001841 |
neural tube formation |
0,005741569 |
0,025340328 |
| GO:0043280 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
0,005742771 |
0,025340328 |
| GO:0045995 |
regulation of embryonic development |
0,005742771 |
0,025340328 |
| GO:0051271 |
negative regulation of cellular component movement |
0,005766105 |
0,025407953 |
| GO:0035967 |
cellular response to topologically incorrect protein |
0,005894005 |
0,025935515 |
| GO:0042692 |
muscle cell differentiation |
0,005907378 |
0,025958358 |
| GO:0001935 |
endothelial cell proliferation |
0,00598813 |
0,026276804 |
| GO:0071333 |
cellular response to glucose stimulus |
0,006004817 |
0,026278827 |
| GO:0071392 |
cellular response to estradiol stimulus |
0,006005157 |
0,026278827 |
| GO:0060043 |
regulation of cardiac muscle cell proliferation |
0,006052348 |
0,026436675 |
| GO:1902903 |
regulation of supramolecular fiber organization |
0,006057893 |
0,026436675 |
| GO:0043903 |
regulation of symbiosis, encompassing mutualism through parasitism |
0,006071327 |
0,026458907 |
| GO:0030833 |
regulation of actin filament polymerization |
0,006131888 |
0,026686173 |
| GO:0014032 |
neural crest cell development |
0,006232975 |
0,027014935 |
| GO:0014855 |
striated muscle cell proliferation |
0,006232975 |
0,027014935 |
| GO:2001021 |
negative regulation of response to DNA damage stimulus |
0,006232975 |
0,027014935 |
| GO:0043062 |
extracellular structure organization |
0,006256399 |
0,02701625 |
| GO:0030260 |
entry into host cell |
0,006275855 |
0,02701625 |
| GO:0044409 |
entry into host |
0,006275855 |
0,02701625 |
| GO:0051806 |
entry into cell of other organism involved in symbiotic interaction |
0,006275855 |
0,02701625 |
| GO:0051828 |
entry into other organism involved in symbiotic interaction |
0,006275855 |
0,02701625 |
| GO:0048524 |
positive regulation of viral process |
0,006355606 |
0,027146312 |
| GO:0051170 |
import into nucleus |
0,006377098 |
0,027146312 |
| GO:0099173 |
postsynapse organization |
0,006377098 |
0,027146312 |
| GO:0032386 |
regulation of intracellular transport |
0,006400265 |
0,027146312 |
| GO:0060149 |
negative regulation of posttranscriptional gene silencing |
0,006408745 |
0,027146312 |
| GO:0060438 |
trachea development |
0,006408745 |
0,027146312 |
| GO:0060716 |
labyrinthine layer blood vessel development |
0,006408745 |
0,027146312 |
| GO:0060967 |
negative regulation of gene silencing by RNA |
0,006408745 |
0,027146312 |
| GO:0072074 |
kidney mesenchyme development |
0,006408745 |
0,027146312 |
| GO:0090201 |
negative regulation of release of cytochrome c from mitochondria |
0,006408745 |
0,027146312 |
| GO:1903798 |
regulation of production of miRNAs involved in gene silencing by miRNA |
0,006408745 |
0,027146312 |
| GO:2000010 |
positive regulation of protein localization to cell surface |
0,006408745 |
0,027146312 |
| GO:0048562 |
embryonic organ morphogenesis |
0,00648053 |
0,027413777 |
| GO:0030520 |
intracellular estrogen receptor signaling pathway |
0,006514968 |
0,027486159 |
| GO:0098930 |
axonal transport |
0,006514968 |
0,027486159 |
| GO:0006405 |
RNA export from nucleus |
0,006556078 |
0,027586232 |
| GO:0071331 |
cellular response to hexose stimulus |
0,006556078 |
0,027586232 |
| GO:0034644 |
cellular response to UV |
0,00661244 |
0,027662974 |
| GO:0071158 |
positive regulation of cell cycle arrest |
0,00661244 |
0,027662974 |
| GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening |
0,006626632 |
0,027662974 |
| GO:0032885 |
regulation of polysaccharide biosynthetic process |
0,006626632 |
0,027662974 |
| GO:0042307 |
positive regulation of protein import into nucleus |
0,006626632 |
0,027662974 |
| GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading |
0,006626632 |
0,027662974 |
| GO:0009914 |
hormone transport |
0,006646238 |
0,027708363 |
| GO:0033673 |
negative regulation of kinase activity |
0,006752384 |
0,028113946 |
| GO:0045814 |
negative regulation of gene expression, epigenetic |
0,006845677 |
0,028427765 |
| GO:0071326 |
cellular response to monosaccharide stimulus |
0,006845677 |
0,028427765 |
| GO:0007093 |
mitotic cell cycle checkpoint |
0,006890083 |
0,028567039 |
| GO:2000377 |
regulation of reactive oxygen species metabolic process |
0,006897224 |
0,028567039 |
| GO:0001658 |
branching involved in ureteric bud morphogenesis |
0,007001817 |
0,028875763 |
| GO:0021885 |
forebrain cell migration |
0,007001817 |
0,028875763 |
| GO:0070527 |
platelet aggregation |
0,007001817 |
0,028875763 |
| GO:0045913 |
positive regulation of carbohydrate metabolic process |
0,007008394 |
0,028875763 |
| GO:0021761 |
limbic system development |
0,00701727 |
0,028875763 |
| GO:0001763 |
morphogenesis of a branching structure |
0,007140387 |
0,029306362 |
| GO:0071897 |
DNA biosynthetic process |
0,007140387 |
0,029306362 |
| GO:0002209 |
behavioral defense response |
0,007289259 |
0,029725106 |
| GO:0046326 |
positive regulation of glucose import |
0,007289259 |
0,029725106 |
| GO:0046825 |
regulation of protein export from nucleus |
0,007289259 |
0,029725106 |
| GO:0060045 |
positive regulation of cardiac muscle cell proliferation |
0,007289259 |
0,029725106 |
| GO:1902742 |
apoptotic process involved in development |
0,007289259 |
0,029725106 |
| GO:0008654 |
phospholipid biosynthetic process |
0,007377155 |
0,029826953 |
| GO:0060420 |
regulation of heart growth |
0,007421229 |
0,029826953 |
| GO:0002320 |
lymphoid progenitor cell differentiation |
0,00742705 |
0,029826953 |
| GO:0003323 |
type B pancreatic cell development |
0,00742705 |
0,029826953 |
| GO:0008356 |
asymmetric cell division |
0,00742705 |
0,029826953 |
| GO:0010002 |
cardioblast differentiation |
0,00742705 |
0,029826953 |
| GO:0032462 |
regulation of protein homooligomerization |
0,00742705 |
0,029826953 |
| GO:0033194 |
response to hydroperoxide |
0,00742705 |
0,029826953 |
| GO:0045655 |
regulation of monocyte differentiation |
0,00742705 |
0,029826953 |
| GO:0051797 |
regulation of hair follicle development |
0,00742705 |
0,029826953 |
| GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
0,00742705 |
0,029826953 |
| GO:1902993 |
positive regulation of amyloid precursor protein catabolic process |
0,00742705 |
0,029826953 |
| GO:0010639 |
negative regulation of organelle organization |
0,007480343 |
0,030003 |
| GO:0010506 |
regulation of autophagy |
0,007566244 |
0,030309224 |
| GO:0110053 |
regulation of actin filament organization |
0,007595219 |
0,030386924 |
| GO:0040013 |
negative regulation of locomotion |
0,007654559 |
0,030585762 |
| GO:0019058 |
viral life cycle |
0,00776185 |
0,030975459 |
| GO:0009798 |
axis specification |
0,007851335 |
0,031214779 |
| GO:0045682 |
regulation of epidermis development |
0,007851335 |
0,031214779 |
| GO:0048864 |
stem cell development |
0,007851335 |
0,031214779 |
| GO:0017038 |
protein import |
0,007909846 |
0,031408044 |
| GO:0045862 |
positive regulation of proteolysis |
0,007943476 |
0,031502152 |
| GO:0060969 |
negative regulation of gene silencing |
0,007994126 |
0,03162396 |
| GO:1904591 |
positive regulation of protein import |
0,007994126 |
0,03162396 |
| GO:0018394 |
peptidyl-lysine acetylation |
0,008010401 |
0,03164888 |
| GO:0007405 |
neuroblast proliferation |
0,008050701 |
0,031689712 |
| GO:0030521 |
androgen receptor signaling pathway |
0,008050701 |
0,031689712 |
| GO:0034113 |
heterotypic cell-cell adhesion |
0,008050701 |
0,031689712 |
| GO:0034620 |
cellular response to unfolded protein |
0,008101715 |
0,031701868 |
| GO:0014902 |
myotube differentiation |
0,008103751 |
0,031701868 |
| GO:0042303 |
molting cycle |
0,008103751 |
0,031701868 |
| GO:0042633 |
hair cycle |
0,008103751 |
0,031701868 |
| GO:0060419 |
heart growth |
0,008103751 |
0,031701868 |
| GO:0032496 |
response to lipopolysaccharide |
0,008165108 |
0,031902563 |
| GO:0031330 |
negative regulation of cellular catabolic process |
0,008279909 |
0,032311316 |
| GO:0001942 |
hair follicle development |
0,008299103 |
0,032346431 |
| GO:0008286 |
insulin receptor signaling pathway |
0,008441104 |
0,032859526 |
| GO:0043244 |
regulation of protein complex disassembly |
0,008492041 |
0,032904264 |
| GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen |
0,008535567 |
0,032904264 |
| GO:0019646 |
aerobic electron transport chain |
0,008535567 |
0,032904264 |
| GO:0032891 |
negative regulation of organic acid transport |
0,008535567 |
0,032904264 |
| GO:0051412 |
response to corticosterone |
0,008535567 |
0,032904264 |
| GO:0055093 |
response to hyperoxia |
0,008535567 |
0,032904264 |
| GO:0070920 |
regulation of production of small RNA involved in gene silencing by RNA |
0,008535567 |
0,032904264 |
| GO:0072010 |
glomerular epithelium development |
0,008535567 |
0,032904264 |
| GO:0010676 |
positive regulation of cellular carbohydrate metabolic process |
0,008613961 |
0,033085865 |
| GO:0032835 |
glomerulus development |
0,008613961 |
0,033085865 |
| GO:0045453 |
bone resorption |
0,008613961 |
0,033085865 |
| GO:0001709 |
cell fate determination |
0,00874228 |
0,033457218 |
| GO:0035315 |
hair cell differentiation |
0,00874228 |
0,033457218 |
| GO:0072210 |
metanephric nephron development |
0,00874228 |
0,033457218 |
| GO:0001892 |
embryonic placenta development |
0,008764917 |
0,033463119 |
| GO:0006112 |
energy reserve metabolic process |
0,008764917 |
0,033463119 |
| GO:0002688 |
regulation of leukocyte chemotaxis |
0,00889384 |
0,033914518 |
| GO:0072331 |
signal transduction by p53 class mediator |
0,009011985 |
0,034323781 |
| GO:0046777 |
protein autophosphorylation |
0,009132698 |
0,03474183 |
| GO:0006606 |
protein import into nucleus |
0,009151697 |
0,034772412 |
| GO:0042982 |
amyloid precursor protein metabolic process |
0,0092039 |
0,034887197 |
| GO:0045815 |
positive regulation of gene expression, epigenetic |
0,0092039 |
0,034887197 |
| GO:0022404 |
molting cycle process |
0,009249161 |
0,034933549 |
| GO:0022405 |
hair cycle process |
0,009249161 |
0,034933549 |
| GO:0098773 |
skin epidermis development |
0,009249161 |
0,034933549 |
| GO:0032963 |
collagen metabolic process |
0,009309414 |
0,03511931 |
| GO:0070317 |
negative regulation of G0 to G1 transition |
0,009534728 |
0,035883962 |
| GO:0097178 |
ruffle assembly |
0,009534728 |
0,035883962 |
| GO:0022010 |
central nervous system myelination |
0,009735936 |
0,036425163 |
| GO:0032291 |
axon ensheathment in central nervous system |
0,009735936 |
0,036425163 |
| GO:0051000 |
positive regulation of nitric-oxide synthase activity |
0,009735936 |
0,036425163 |
| GO:0060065 |
uterus development |
0,009735936 |
0,036425163 |
| GO:0060575 |
intestinal epithelial cell differentiation |
0,009735936 |
0,036425163 |
| GO:0043297 |
apical junction assembly |
0,009821105 |
0,036657352 |
| GO:0045669 |
positive regulation of osteoblast differentiation |
0,009821105 |
0,036657352 |
| GO:0006109 |
regulation of carbohydrate metabolic process |
0,009953339 |
0,037107259 |
| GO:0050808 |
synapse organization |
0,010010249 |
0,037275626 |
| GO:0010906 |
regulation of glucose metabolic process |
0,010182937 |
0,037874218 |
| GO:0014033 |
neural crest cell differentiation |
0,010274457 |
0,037973372 |
| GO:0034333 |
adherens junction assembly |
0,010274457 |
0,037973372 |
| GO:0045778 |
positive regulation of ossification |
0,010274457 |
0,037973372 |
| GO:0046849 |
bone remodeling |
0,010274457 |
0,037973372 |
| GO:0000956 |
nuclear-transcribed mRNA catabolic process |
0,010275339 |
0,037973372 |
| GO:0051402 |
neuron apoptotic process |
0,01028141 |
0,037973372 |
| GO:0006986 |
response to unfolded protein |
0,010298279 |
0,037991447 |
| GO:0010470 |
regulation of gastrulation |
0,010372435 |
0,038131998 |
| GO:0017145 |
stem cell division |
0,010372435 |
0,038131998 |
| GO:0051154 |
negative regulation of striated muscle cell differentiation |
0,010372435 |
0,038131998 |
| GO:0060675 |
ureteric bud morphogenesis |
0,010466154 |
0,038432002 |
| GO:0050792 |
regulation of viral process |
0,010605211 |
0,038897606 |
| GO:0030510 |
regulation of BMP signaling pathway |
0,010816258 |
0,039625869 |
| GO:0035303 |
regulation of dephosphorylation |
0,010943074 |
0,040044223 |
| GO:0006541 |
glutamine metabolic process |
0,011029577 |
0,040146393 |
| GO:0048714 |
positive regulation of oligodendrocyte differentiation |
0,011029577 |
0,040146393 |
| GO:0060055 |
angiogenesis involved in wound healing |
0,011029577 |
0,040146393 |
| GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
0,011029577 |
0,040146393 |
| GO:0010950 |
positive regulation of endopeptidase activity |
0,011034264 |
0,040146393 |
| GO:0045428 |
regulation of nitric oxide biosynthetic process |
0,011139609 |
0,040424356 |
| GO:0072171 |
mesonephric tubule morphogenesis |
0,011139609 |
0,040424356 |
| GO:0002237 |
response to molecule of bacterial origin |
0,011207353 |
0,040424356 |
| GO:0021795 |
cerebral cortex cell migration |
0,011256323 |
0,040424356 |
| GO:0032881 |
regulation of polysaccharide metabolic process |
0,011256323 |
0,040424356 |
| GO:0032924 |
activin receptor signaling pathway |
0,011256323 |
0,040424356 |
| GO:0045429 |
positive regulation of nitric oxide biosynthetic process |
0,011256323 |
0,040424356 |
| GO:0045687 |
positive regulation of glial cell differentiation |
0,011256323 |
0,040424356 |
| GO:0045746 |
negative regulation of Notch signaling pathway |
0,011256323 |
0,040424356 |
| GO:0045773 |
positive regulation of axon extension |
0,011256323 |
0,040424356 |
| GO:0071364 |
cellular response to epidermal growth factor stimulus |
0,011256323 |
0,040424356 |
| GO:0007163 |
establishment or maintenance of cell polarity |
0,011289045 |
0,040424356 |
| GO:0030178 |
negative regulation of Wnt signaling pathway |
0,011289045 |
0,040424356 |
| GO:0043523 |
regulation of neuron apoptotic process |
0,011289045 |
0,040424356 |
| GO:2001056 |
positive regulation of cysteine-type endopeptidase activity |
0,011551958 |
0,041319173 |
| GO:0022612 |
gland morphogenesis |
0,011603092 |
0,041455335 |
| GO:0022618 |
ribonucleoprotein complex assembly |
0,011821923 |
0,042189658 |
| GO:2000573 |
positive regulation of DNA biosynthetic process |
0,011842024 |
0,04221391 |
| GO:0007589 |
body fluid secretion |
0,011960011 |
0,042491274 |
| GO:0036473 |
cell death in response to oxidative stress |
0,011960011 |
0,042491274 |
| GO:0048704 |
embryonic skeletal system morphogenesis |
0,011960011 |
0,042491274 |
| GO:0016331 |
morphogenesis of embryonic epithelium |
0,011993182 |
0,042561462 |
| GO:0010811 |
positive regulation of cell-substrate adhesion |
0,012106813 |
0,042819181 |
| GO:0010828 |
positive regulation of glucose transmembrane transport |
0,012187271 |
0,042819181 |
| GO:0014002 |
astrocyte development |
0,012187271 |
0,042819181 |
| GO:0014003 |
oligodendrocyte development |
0,012187271 |
0,042819181 |
| GO:0035307 |
positive regulation of protein dephosphorylation |
0,012187271 |
0,042819181 |
| GO:0045601 |
regulation of endothelial cell differentiation |
0,012187271 |
0,042819181 |
| GO:0051489 |
regulation of filopodium assembly |
0,012187271 |
0,042819181 |
| GO:1903573 |
negative regulation of response to endoplasmic reticulum stress |
0,012187271 |
0,042819181 |
| GO:1904407 |
positive regulation of nitric oxide metabolic process |
0,012187271 |
0,042819181 |
| GO:0051147 |
regulation of muscle cell differentiation |
0,012211288 |
0,042856104 |
| GO:0032528 |
microvillus organization |
0,012417701 |
0,043293176 |
| GO:0050996 |
positive regulation of lipid catabolic process |
0,012417701 |
0,043293176 |
| GO:0090023 |
positive regulation of neutrophil chemotaxis |
0,012417701 |
0,043293176 |
| GO:0099563 |
modification of synaptic structure |
0,012417701 |
0,043293176 |
| GO:1905564 |
positive regulation of vascular endothelial cell proliferation |
0,012417701 |
0,043293176 |
| GO:2000209 |
regulation of anoikis |
0,012417701 |
0,043293176 |
| GO:0055088 |
lipid homeostasis |
0,012446682 |
0,043346584 |
| GO:1901214 |
regulation of neuron death |
0,012467405 |
0,043371144 |
| GO:1901216 |
positive regulation of neuron death |
0,012562686 |
0,043627834 |
| GO:0071230 |
cellular response to amino acid stimulus |
0,012573939 |
0,043627834 |
| GO:0070997 |
neuron death |
0,012589137 |
0,043627834 |
| GO:0006338 |
chromatin remodeling |
0,012623701 |
0,043627834 |
| GO:0010821 |
regulation of mitochondrion organization |
0,012623701 |
0,043627834 |
| GO:0061138 |
morphogenesis of a branching epithelium |
0,012623701 |
0,043627834 |
| GO:1903050 |
regulation of proteolysis involved in cellular protein catabolic process |
0,012756378 |
0,044038398 |
| GO:0097237 |
cellular response to toxic substance |
0,012908937 |
0,044384704 |
| GO:0001678 |
cellular glucose homeostasis |
0,01291265 |
0,044384704 |
| GO:0016202 |
regulation of striated muscle tissue development |
0,01291265 |
0,044384704 |
| GO:0030902 |
hindbrain development |
0,01291265 |
0,044384704 |
| GO:0038061 |
NIK/NF-kappaB signaling |
0,013046395 |
0,044747466 |
| GO:0050770 |
regulation of axonogenesis |
0,013046395 |
0,044747466 |
| GO:0032388 |
positive regulation of intracellular transport |
0,013144665 |
0,044867062 |
| GO:0002062 |
chondrocyte differentiation |
0,013161291 |
0,044867062 |
| GO:0001974 |
blood vessel remodeling |
0,013166116 |
0,044867062 |
| GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
0,013166116 |
0,044867062 |
| GO:0048538 |
thymus development |
0,013166116 |
0,044867062 |
| GO:0048701 |
embryonic cranial skeleton morphogenesis |
0,013166116 |
0,044867062 |
| GO:0050810 |
regulation of steroid biosynthetic process |
0,01318637 |
0,04488787 |
| GO:0008088 |
axo-dendritic transport |
0,013335879 |
0,045299605 |
| GO:0071300 |
cellular response to retinoic acid |
0,013335879 |
0,045299605 |
| GO:0030168 |
platelet activation |
0,013391274 |
0,045342133 |
| GO:0051017 |
actin filament bundle assembly |
0,013391274 |
0,045342133 |
| GO:0090316 |
positive regulation of intracellular protein transport |
0,013391274 |
0,045342133 |
| GO:0043409 |
negative regulation of MAPK cascade |
0,013479519 |
0,045592267 |
| GO:0000075 |
cell cycle checkpoint |
0,013541768 |
0,045754038 |
| GO:0062012 |
regulation of small molecule metabolic process |
0,013649314 |
0,046068346 |
| GO:0070371 |
ERK1 and ERK2 cascade |
0,013729939 |
0,046193884 |
| GO:0006914 |
autophagy |
0,013730189 |
0,046193884 |
| GO:0061919 |
process utilizing autophagic mechanism |
0,013730189 |
0,046193884 |
| GO:0051258 |
protein polymerization |
0,013805277 |
0,04627887 |
| GO:0001945 |
lymph vessel development |
0,013901319 |
0,04627887 |
| GO:0003309 |
type B pancreatic cell differentiation |
0,013901319 |
0,04627887 |
| GO:0008334 |
histone mRNA metabolic process |
0,013901319 |
0,04627887 |
| GO:0032461 |
positive regulation of protein oligomerization |
0,013901319 |
0,04627887 |
| GO:0034110 |
regulation of homotypic cell-cell adhesion |
0,013901319 |
0,04627887 |
| GO:0060561 |
apoptotic process involved in morphogenesis |
0,013901319 |
0,04627887 |
| GO:0060571 |
morphogenesis of an epithelial fold |
0,013901319 |
0,04627887 |
| GO:1900101 |
regulation of endoplasmic reticulum unfolded protein response |
0,013901319 |
0,04627887 |
| GO:2000679 |
positive regulation of transcription regulatory region DNA binding |
0,013901319 |
0,04627887 |
| GO:1903708 |
positive regulation of hemopoiesis |
0,013923217 |
0,046303186 |
| GO:0060348 |
bone development |
0,013947807 |
0,046336391 |
| GO:0033077 |
T cell differentiation in thymus |
0,014128358 |
0,046887109 |
| GO:0072593 |
reactive oxygen species metabolic process |
0,014159124 |
0,046907521 |
| GO:0005978 |
glycogen biosynthetic process |
0,014193649 |
0,046907521 |
| GO:0009250 |
glucan biosynthetic process |
0,014193649 |
0,046907521 |
| GO:0022602 |
ovulation cycle process |
0,014193649 |
0,046907521 |
| GO:0032271 |
regulation of protein polymerization |
0,014362898 |
0,047350017 |
| GO:0010977 |
negative regulation of neuron projection development |
0,014387241 |
0,047350017 |
| GO:1901861 |
regulation of muscle tissue development |
0,014387241 |
0,047350017 |
| GO:1903707 |
negative regulation of hemopoiesis |
0,014387241 |
0,047350017 |
| GO:0014020 |
primary neural tube formation |
0,014498158 |
0,047490829 |
| GO:0051591 |
response to cAMP |
0,014498158 |
0,047490829 |
| GO:0060996 |
dendritic spine development |
0,014498158 |
0,047490829 |
| GO:0002446 |
neutrophil mediated immunity |
0,014516058 |
0,047490829 |
| GO:0034976 |
response to endoplasmic reticulum stress |
0,01451984 |
0,047490829 |
| GO:0051348 |
negative regulation of transferase activity |
0,01451984 |
0,047490829 |
| GO:0045667 |
regulation of osteoblast differentiation |
0,01486437 |
0,048517664 |
| GO:0048706 |
embryonic skeletal system development |
0,01486437 |
0,048517664 |
| GO:0016573 |
histone acetylation |
0,014904958 |
0,048550246 |
| GO:0048634 |
regulation of muscle organ development |
0,014904958 |
0,048550246 |
| GO:0007568 |
aging |
0,015088537 |
0,049097814 |
| GO:0045646 |
regulation of erythrocyte differentiation |
0,01527062 |
0,049363129 |
| GO:0050435 |
amyloid-beta metabolic process |
0,01527062 |
0,049363129 |
| GO:0061614 |
pri-miRNA transcription by RNA polymerase II |
0,01527062 |
0,049363129 |
| GO:0120163 |
negative regulation of cold-induced thermogenesis |
0,01527062 |
0,049363129 |
| GO:0031345 |
negative regulation of cell projection organization |
0,015319223 |
0,049363129 |
| GO:0030509 |
BMP signaling pathway |
0,015436076 |
0,049363129 |
| GO:0043271 |
negative regulation of ion transport |
0,015436076 |
0,049363129 |
| GO:0061572 |
actin filament bundle organization |
0,015436076 |
0,049363129 |
| GO:0018209 |
peptidyl-serine modification |
0,015443715 |
0,049363129 |
| GO:0071426 |
ribonucleoprotein complex export from nucleus |
0,015465414 |
0,049363129 |
| GO:0010996 |
response to auditory stimulus |
0,015481253 |
0,049363129 |
| GO:0022011 |
myelination in peripheral nervous system |
0,015481253 |
0,049363129 |
| GO:0032292 |
peripheral nervous system axon ensheathment |
0,015481253 |
0,049363129 |
| GO:0034114 |
regulation of heterotypic cell-cell adhesion |
0,015481253 |
0,049363129 |
| GO:0045992 |
negative regulation of embryonic development |
0,015481253 |
0,049363129 |
| GO:0060074 |
synapse maturation |
0,015481253 |
0,049363129 |
| GO:0060740 |
prostate gland epithelium morphogenesis |
0,015481253 |
0,049363129 |
| GO:0060914 |
heart formation |
0,015481253 |
0,049363129 |
| GO:0071624 |
positive regulation of granulocyte chemotaxis |
0,015481253 |
0,049363129 |
| GO:1903203 |
regulation of oxidative stress-induced neuron death |
0,015481253 |
0,049363129 |
| GO:0051346 |
negative regulation of hydrolase activity |
0,015612601 |
0,049731958 |
| GO:0071824 |
protein-DNA complex subunit organization |
0,01564402 |
0,049782057 |
| GO:0006644 |
phospholipid metabolic process |
0,015792612 |
0,050149521 |
| GO:0006305 |
DNA alkylation |
0,015806916 |
0,050149521 |
| GO:0006306 |
DNA methylation |
0,015806916 |
0,050149521 |
| GO:0070301 |
cellular response to hydrogen peroxide |
0,015898111 |
0,05038846 |
| GO:0043467 |
regulation of generation of precursor metabolites and energy |
0,01598078 |
0,050599926 |
| GO:0022409 |
positive regulation of cell-cell adhesion |
0,016017847 |
0,050666727 |
| GO:0010595 |
positive regulation of endothelial cell migration |
0,016083539 |
0,050773276 |
| GO:0071166 |
ribonucleoprotein complex localization |
0,016083539 |
0,050773276 |
| GO:0060759 |
regulation of response to cytokine stimulus |
0,016305432 |
0,051422594 |
| GO:0044764 |
multi-organism cellular process |
0,016397732 |
0,051457927 |
| GO:0046850 |
regulation of bone remodeling |
0,016397732 |
0,051457927 |
| GO:0055010 |
ventricular cardiac muscle tissue morphogenesis |
0,016397732 |
0,051457927 |
| GO:0055023 |
positive regulation of cardiac muscle tissue growth |
0,016397732 |
0,051457927 |
| GO:0090199 |
regulation of release of cytochrome c from mitochondria |
0,016397732 |
0,051457927 |
| GO:0034446 |
substrate adhesion-dependent cell spreading |
0,016631979 |
0,051612173 |
| GO:0035282 |
segmentation |
0,016631979 |
0,051612173 |
| GO:0055024 |
regulation of cardiac muscle tissue development |
0,016631979 |
0,051612173 |
| GO:0061640 |
cytoskeleton-dependent cytokinesis |
0,016631979 |
0,051612173 |
| GO:0033555 |
multicellular organismal response to stress |
0,01669395 |
0,051612173 |
| GO:1903524 |
positive regulation of blood circulation |
0,01669395 |
0,051612173 |
| GO:0003211 |
cardiac ventricle formation |
0,016772244 |
0,051612173 |
| GO:0007220 |
Notch receptor processing |
0,016772244 |
0,051612173 |
| GO:0032000 |
positive regulation of fatty acid beta-oxidation |
0,016772244 |
0,051612173 |
| GO:0032070 |
regulation of deoxyribonuclease activity |
0,016772244 |
0,051612173 |
| GO:0032463 |
negative regulation of protein homooligomerization |
0,016772244 |
0,051612173 |
| GO:0032464 |
positive regulation of protein homooligomerization |
0,016772244 |
0,051612173 |
| GO:0044803 |
multi-organism membrane organization |
0,016772244 |
0,051612173 |
| GO:0045792 |
negative regulation of cell size |
0,016772244 |
0,051612173 |
| GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development |
0,016772244 |
0,051612173 |
| GO:0072015 |
glomerular visceral epithelial cell development |
0,016772244 |
0,051612173 |
| GO:0072203 |
cell proliferation involved in metanephros development |
0,016772244 |
0,051612173 |
| GO:0072610 |
interleukin-12 secretion |
0,016772244 |
0,051612173 |
| GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA |
0,016772244 |
0,051612173 |
| GO:2001225 |
regulation of chloride transport |
0,016772244 |
0,051612173 |
| GO:0019080 |
viral gene expression |
0,016815629 |
0,051695537 |
| GO:0071826 |
ribonucleoprotein complex subunit organization |
0,016832938 |
0,051698656 |
| GO:0097191 |
extrinsic apoptotic signaling pathway |
0,017050079 |
0,052314911 |
| GO:0003148 |
outflow tract septum morphogenesis |
0,017158147 |
0,052342768 |
| GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle |
0,017158147 |
0,052342768 |
| GO:0035883 |
enteroendocrine cell differentiation |
0,017158147 |
0,052342768 |
| GO:0036475 |
neuron death in response to oxidative stress |
0,017158147 |
0,052342768 |
| GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
0,017158147 |
0,052342768 |
| GO:2000191 |
regulation of fatty acid transport |
0,017158147 |
0,052342768 |
| GO:0043406 |
positive regulation of MAP kinase activity |
0,017317872 |
0,052779277 |
| GO:0048839 |
inner ear development |
0,017337409 |
0,05278811 |
| GO:0005977 |
glycogen metabolic process |
0,017613431 |
0,053321497 |
| GO:0060998 |
regulation of dendritic spine development |
0,017613431 |
0,053321497 |
| GO:0072078 |
nephron tubule morphogenesis |
0,017613431 |
0,053321497 |
| GO:1900006 |
positive regulation of dendrite development |
0,017613431 |
0,053321497 |
| GO:1900182 |
positive regulation of protein localization to nucleus |
0,017613431 |
0,053321497 |
| GO:1903036 |
positive regulation of response to wounding |
0,017613431 |
0,053321497 |
| GO:0018393 |
internal peptidyl-lysine acetylation |
0,017698213 |
0,053527082 |
| GO:0046887 |
positive regulation of hormone secretion |
0,018042762 |
0,054517178 |
| GO:0060249 |
anatomical structure homeostasis |
0,018092659 |
0,05461593 |
| GO:0021549 |
cerebellum development |
0,018169105 |
0,054794558 |
| GO:0016236 |
macroautophagy |
0,018522623 |
0,055620819 |
| GO:0001894 |
tissue homeostasis |
0,018525279 |
0,055620819 |
| GO:0006457 |
protein folding |
0,018525279 |
0,055620819 |
| GO:0006073 |
cellular glucan metabolic process |
0,018565801 |
0,055620819 |
| GO:0006695 |
cholesterol biosynthetic process |
0,018565801 |
0,055620819 |
| GO:0043242 |
negative regulation of protein complex disassembly |
0,018565801 |
0,055620819 |
| GO:0044042 |
glucan metabolic process |
0,018565801 |
0,055620819 |
| GO:0001961 |
positive regulation of cytokine-mediated signaling pathway |
0,018804977 |
0,055823195 |
| GO:0014009 |
glial cell proliferation |
0,018804977 |
0,055823195 |
| GO:0045540 |
regulation of cholesterol biosynthetic process |
0,018804977 |
0,055823195 |
| GO:0106118 |
regulation of sterol biosynthetic process |
0,018804977 |
0,055823195 |
| GO:1903793 |
positive regulation of anion transport |
0,018804977 |
0,055823195 |
| GO:0001958 |
endochondral ossification |
0,018932472 |
0,055823195 |
| GO:0003180 |
aortic valve morphogenesis |
0,018932472 |
0,055823195 |
| GO:0008045 |
motor neuron axon guidance |
0,018932472 |
0,055823195 |
| GO:0032770 |
positive regulation of monooxygenase activity |
0,018932472 |
0,055823195 |
| GO:0035116 |
embryonic hindlimb morphogenesis |
0,018932472 |
0,055823195 |
| GO:0036075 |
replacement ossification |
0,018932472 |
0,055823195 |
| GO:0036296 |
response to increased oxygen levels |
0,018932472 |
0,055823195 |
| GO:0045577 |
regulation of B cell differentiation |
0,018932472 |
0,055823195 |
| GO:0051123 |
RNA polymerase II preinitiation complex assembly |
0,018932472 |
0,055823195 |
| GO:0060512 |
prostate gland morphogenesis |
0,018932472 |
0,055823195 |
| GO:1902003 |
regulation of amyloid-beta formation |
0,018932472 |
0,055823195 |
| GO:1903792 |
negative regulation of anion transport |
0,018932472 |
0,055823195 |
| GO:0048259 |
regulation of receptor-mediated endocytosis |
0,018972986 |
0,05589071 |
| GO:0034504 |
protein localization to nucleus |
0,01917177 |
0,056423899 |
| GO:0030198 |
extracellular matrix organization |
0,019479649 |
0,057276877 |
| GO:1902653 |
secondary alcohol biosynthetic process |
0,019551483 |
0,057434864 |
| GO:0043900 |
regulation of multi-organism process |
0,019781596 |
0,057861794 |
| GO:0050999 |
regulation of nitric-oxide synthase activity |
0,020086296 |
0,057861794 |
| GO:0010952 |
positive regulation of peptidase activity |
0,020124968 |
0,057861794 |
| GO:0046683 |
response to organophosphorus |
0,020164109 |
0,057861794 |
| GO:0051251 |
positive regulation of lymphocyte activation |
0,02022077 |
0,057861794 |
| GO:0003264 |
regulation of cardioblast proliferation |
0,020225711 |
0,057861794 |
| GO:0009950 |
dorsal/ventral axis specification |
0,020225711 |
0,057861794 |
| GO:0033327 |
Leydig cell differentiation |
0,020225711 |
0,057861794 |
| GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
0,020225711 |
0,057861794 |
| GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway |
0,020225711 |
0,057861794 |
| GO:0045793 |
positive regulation of cell size |
0,020225711 |
0,057861794 |
| GO:0048096 |
chromatin-mediated maintenance of transcription |
0,020225711 |
0,057861794 |
| GO:0048853 |
forebrain morphogenesis |
0,020225711 |
0,057861794 |
| GO:0060379 |
cardiac muscle cell myoblast differentiation |
0,020225711 |
0,057861794 |
| GO:0060439 |
trachea morphogenesis |
0,020225711 |
0,057861794 |
| GO:0060525 |
prostate glandular acinus development |
0,020225711 |
0,057861794 |
| GO:0060736 |
prostate gland growth |
0,020225711 |
0,057861794 |
| GO:0060767 |
epithelial cell proliferation involved in prostate gland development |
0,020225711 |
0,057861794 |
| GO:0060837 |
blood vessel endothelial cell differentiation |
0,020225711 |
0,057861794 |
| GO:0061307 |
cardiac neural crest cell differentiation involved in heart development |
0,020225711 |
0,057861794 |
| GO:0061308 |
cardiac neural crest cell development involved in heart development |
0,020225711 |
0,057861794 |
| GO:0070106 |
interleukin-27-mediated signaling pathway |
0,020225711 |
0,057861794 |
| GO:0070278 |
extracellular matrix constituent secretion |
0,020225711 |
0,057861794 |
| GO:0070587 |
regulation of cell-cell adhesion involved in gastrulation |
0,020225711 |
0,057861794 |
| GO:0070757 |
interleukin-35-mediated signaling pathway |
0,020225711 |
0,057861794 |
| GO:0072310 |
glomerular epithelial cell development |
0,020225711 |
0,057861794 |
| GO:1904321 |
response to forskolin |
0,020225711 |
0,057861794 |
| GO:1904322 |
cellular response to forskolin |
0,020225711 |
0,057861794 |
| GO:1905383 |
protein localization to presynapse |
0,020225711 |
0,057861794 |
| GO:0018105 |
peptidyl-serine phosphorylation |
0,02033637 |
0,058125955 |
| GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
0,020570886 |
0,058585137 |
| GO:0006278 |
RNA-dependent DNA biosynthetic process |
0,020570886 |
0,058585137 |
| GO:0006809 |
nitric oxide biosynthetic process |
0,020570886 |
0,058585137 |
| GO:1901224 |
positive regulation of NIK/NF-kappaB signaling |
0,020570886 |
0,058585137 |
| GO:0055017 |
cardiac muscle tissue growth |
0,020652893 |
0,058765937 |
| GO:0046890 |
regulation of lipid biosynthetic process |
0,020719177 |
0,058775721 |
| GO:0014044 |
Schwann cell development |
0,020804538 |
0,058775721 |
| GO:0021799 |
cerebral cortex radially oriented cell migration |
0,020804538 |
0,058775721 |
| GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway |
0,020804538 |
0,058775721 |
| GO:0070229 |
negative regulation of lymphocyte apoptotic process |
0,020804538 |
0,058775721 |
| GO:1902624 |
positive regulation of neutrophil migration |
0,020804538 |
0,058775721 |
| GO:1903846 |
positive regulation of cellular response to transforming growth factor beta stimulus |
0,020804538 |
0,058775721 |
| GO:2000171 |
negative regulation of dendrite development |
0,020804538 |
0,058775721 |
| GO:0006475 |
internal protein amino acid acetylation |
0,020848971 |
0,058848846 |
| GO:0030010 |
establishment of cell polarity |
0,020908298 |
0,058963846 |
| GO:0031529 |
ruffle organization |
0,021420132 |
0,060300079 |
| GO:1900024 |
regulation of substrate adhesion-dependent cell spreading |
0,021420132 |
0,060300079 |
| GO:0035051 |
cardiocyte differentiation |
0,021523932 |
0,060446045 |
| GO:0021510 |
spinal cord development |
0,0215295 |
0,060446045 |
| GO:0042136 |
neurotransmitter biosynthetic process |
0,0215295 |
0,060446045 |
| GO:0043405 |
regulation of MAP kinase activity |
0,021571773 |
0,060446045 |
| GO:0055021 |
regulation of cardiac muscle tissue growth |
0,021624402 |
0,060446045 |
| GO:0061333 |
renal tubule morphogenesis |
0,021624402 |
0,060446045 |
| GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator |
0,021624402 |
0,060446045 |
| GO:1903313 |
positive regulation of mRNA metabolic process |
0,021624402 |
0,060446045 |
| GO:0048738 |
cardiac muscle tissue development |
0,021754227 |
0,060755412 |
| GO:0051056 |
regulation of small GTPase mediated signal transduction |
0,022036762 |
0,061490348 |
| GO:0043312 |
neutrophil degranulation |
0,02205778 |
0,061494913 |
| GO:0007265 |
Ras protein signal transduction |
0,022216862 |
0,061884037 |
| GO:0021675 |
nerve development |
0,022712407 |
0,06281086 |
| GO:0030193 |
regulation of blood coagulation |
0,022712407 |
0,06281086 |
| GO:1900034 |
regulation of cellular response to heat |
0,022712407 |
0,06281086 |
| GO:0021772 |
olfactory bulb development |
0,022774503 |
0,06281086 |
| GO:0050690 |
regulation of defense response to virus by virus |
0,022774503 |
0,06281086 |
| GO:0070168 |
negative regulation of biomineral tissue development |
0,022774503 |
0,06281086 |
| GO:0090022 |
regulation of neutrophil chemotaxis |
0,022774503 |
0,06281086 |
| GO:1902751 |
positive regulation of cell cycle G2/M phase transition |
0,022774503 |
0,06281086 |
| GO:0060326 |
cell chemotaxis |
0,022785696 |
0,06281086 |
| GO:0000186 |
activation of MAPKK activity |
0,022806969 |
0,06281086 |
| GO:0030195 |
negative regulation of blood coagulation |
0,022806969 |
0,06281086 |
| GO:0032964 |
collagen biosynthetic process |
0,022806969 |
0,06281086 |
| GO:0070228 |
regulation of lymphocyte apoptotic process |
0,022806969 |
0,06281086 |
| GO:0006469 |
negative regulation of protein kinase activity |
0,022916325 |
0,063057291 |
| GO:0002283 |
neutrophil activation involved in immune response |
0,023237752 |
0,06388633 |
| GO:1904659 |
glucose transmembrane transport |
0,023357424 |
0,06415974 |
| GO:0009199 |
ribonucleoside triphosphate metabolic process |
0,023476622 |
0,064431377 |
| GO:0071772 |
response to BMP |
0,023641432 |
0,06444119 |
| GO:0071773 |
cellular response to BMP stimulus |
0,023641432 |
0,06444119 |
| GO:0022617 |
extracellular matrix disassembly |
0,023835261 |
0,06444119 |
| GO:1900046 |
regulation of hemostasis |
0,023835261 |
0,06444119 |
| GO:0002551 |
mast cell chemotaxis |
0,023947364 |
0,06444119 |
| GO:0002903 |
negative regulation of B cell apoptotic process |
0,023947364 |
0,06444119 |
| GO:0003161 |
cardiac conduction system development |
0,023947364 |
0,06444119 |
| GO:0003207 |
cardiac chamber formation |
0,023947364 |
0,06444119 |
| GO:0033197 |
response to vitamin E |
0,023947364 |
0,06444119 |
| GO:0042118 |
endothelial cell activation |
0,023947364 |
0,06444119 |
| GO:0045472 |
response to ether |
0,023947364 |
0,06444119 |
| GO:0045579 |
positive regulation of B cell differentiation |
0,023947364 |
0,06444119 |
| GO:0045955 |
negative regulation of calcium ion-dependent exocytosis |
0,023947364 |
0,06444119 |
| GO:0060742 |
epithelial cell differentiation involved in prostate gland development |
0,023947364 |
0,06444119 |
| GO:0070586 |
cell-cell adhesion involved in gastrulation |
0,023947364 |
0,06444119 |
| GO:0072017 |
distal tubule development |
0,023947364 |
0,06444119 |
| GO:0090331 |
negative regulation of platelet aggregation |
0,023947364 |
0,06444119 |
| GO:0097531 |
mast cell migration |
0,023947364 |
0,06444119 |
| GO:0098974 |
postsynaptic actin cytoskeleton organization |
0,023947364 |
0,06444119 |
| GO:0099640 |
axo-dendritic protein transport |
0,023947364 |
0,06444119 |
| GO:1902337 |
regulation of apoptotic process involved in morphogenesis |
0,023947364 |
0,06444119 |
| GO:1903894 |
regulation of IRE1-mediated unfolded protein response |
0,023947364 |
0,06444119 |
| GO:1905244 |
regulation of modification of synaptic structure |
0,023947364 |
0,06444119 |
| GO:0035304 |
regulation of protein dephosphorylation |
0,024076138 |
0,064732811 |
| GO:1900047 |
negative regulation of hemostasis |
0,024247248 |
0,065137666 |
| GO:0000910 |
cytokinesis |
0,024378676 |
0,065435328 |
| GO:0006473 |
protein acetylation |
0,024552575 |
0,065790773 |
| GO:0034764 |
positive regulation of transmembrane transport |
0,024552575 |
0,065790773 |
| GO:0021988 |
olfactory lobe development |
0,024842376 |
0,066231688 |
| GO:0060292 |
long-term synaptic depression |
0,024842376 |
0,066231688 |
| GO:0097106 |
postsynaptic density organization |
0,024842376 |
0,066231688 |
| GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
0,024842376 |
0,066231688 |
| GO:1902253 |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
0,024842376 |
0,066231688 |
| GO:1902895 |
positive regulation of pri-miRNA transcription by RNA polymerase II |
0,024842376 |
0,066231688 |
| GO:0016126 |
sterol biosynthetic process |
0,024993306 |
0,066578129 |
| GO:0032874 |
positive regulation of stress-activated MAPK cascade |
0,025131888 |
0,066835056 |
| GO:0051262 |
protein tetramerization |
0,025131888 |
0,066835056 |
| GO:0043414 |
macromolecule methylation |
0,025446414 |
0,067614821 |
| GO:0010823 |
negative regulation of mitochondrion organization |
0,025741365 |
0,068170172 |
| GO:0042306 |
regulation of protein import into nucleus |
0,025741365 |
0,068170172 |
| GO:0044380 |
protein localization to cytoskeleton |
0,025741365 |
0,068170172 |
| GO:0070830 |
bicellular tight junction assembly |
0,025741365 |
0,068170172 |
| GO:0016525 |
negative regulation of angiogenesis |
0,025901222 |
0,068479196 |
| GO:0070304 |
positive regulation of stress-activated protein kinase signaling cascade |
0,025901222 |
0,068479196 |
| GO:0016925 |
protein sumoylation |
0,026186869 |
0,069119206 |
| GO:0046209 |
nitric oxide metabolic process |
0,026186869 |
0,069119206 |
| GO:0006406 |
mRNA export from nucleus |
0,026290054 |
0,069161405 |
| GO:0022037 |
metencephalon development |
0,026290054 |
0,069161405 |
| GO:0035305 |
negative regulation of dephosphorylation |
0,026290054 |
0,069161405 |
| GO:0071427 |
mRNA-containing ribonucleoprotein complex export from nucleus |
0,026290054 |
0,069161405 |
| GO:1990778 |
protein localization to cell periphery |
0,026572007 |
0,069845226 |
| GO:0099003 |
vesicle-mediated transport in synapse |
0,026647465 |
0,069898467 |
| GO:0010675 |
regulation of cellular carbohydrate metabolic process |
0,026658357 |
0,069898467 |
| GO:0038127 |
ERBB signaling pathway |
0,026658357 |
0,069898467 |
| GO:0046488 |
phosphatidylinositol metabolic process |
0,02668683 |
0,069915341 |